CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: chalcogen oxoanion
Accession: CHEBI:33485
browse the term
Synonyms: related_synonym: chalcogen oxoanions
G
Alb
albumin
affects binding
ISO
chromotrope 2R binds to ALB protein
CTD
PMID:19347248
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
Benzenesulfonates analog inhibits the reaction [SLC10A1 protein results in increased transport of Taurocholic Acid]
CTD
PMID:22641618
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Casp3
caspase 3
multiple interactions
ISO
brilliant green results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:26177467
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions
ISO
brilliant green results in increased cleavage of and results in increased activity of CASP7 protein
CTD
PMID:26177467
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Ccnd1
cyclin D1
decreases expression
ISO
brilliant green results in decreased expression of CCND1 protein
CTD
PMID:26177467
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
decreases expression
ISO
brilliant green results in decreased expression of IKBKE protein
CTD
PMID:26177467
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
G
Lonp1
lon peptidase 1, mitochondrial
increases expression
ISO
brilliant green results in increased expression of LONP1 mRNA
CTD
PMID:21215310
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
brilliant green inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Txn1
thioredoxin 1
increases oxidation
ISO
brilliant green results in increased oxidation of TXN protein
CTD
PMID:21215310
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
decreases expression affects response to substance multiple interactions
ISO
brilliant green results in decreased expression of TXN2 protein TXN2 protein affects the susceptibility to brilliant green brilliant green results in increased oxidation of and results in increased degradation of TXN2 protein
CTD
PMID:21215310
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
App
amyloid beta precursor protein
multiple interactions affects binding
EXP ISO
Congo Red inhibits the reaction [APP protein binds to APP protein] Congo Red binds to APP protein
CTD
PMID:17323972 PMID:17406451
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Prnp
prion protein
decreases expression
ISO
Congo Red results in decreased expression of PRNP protein alternative form
CTD
PMID:11994310
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:119,177,485...119,203,937
G
Ache
acetylcholinesterase
increases activity
ISO
Dithionite results in increased activity of ACHE protein
CTD
PMID:33617922
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acp5
acid phosphatase 5, tartrate resistant
decreases activity multiple interactions
EXP
Dithionite results in decreased activity of ACP5 protein ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein]
CTD
PMID:6886379
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]
CTD
PMID:21803128
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
EXP ISO
[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein] dihydroactinidiolide inhibits the reaction [Dithionite results in increased expression of BAX protein]
CTD
PMID:21803128 PMID:33617922
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
EXP ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein] dihydroactinidiolide inhibits the reaction [Dithionite results in decreased expression of BCL2 protein]
CTD
PMID:21803128 PMID:33617922
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
C5
complement C5
multiple interactions
ISO
Dithionite inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of C5 protein]; Dithionite inhibits the reaction [Asbestos, Serpentine results in increased cleavage of C5 protein]
CTD
PMID:10777245
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Casp3
caspase 3
multiple interactions increases expression increases activity
EXP ISO
[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Dithionite co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form] Dithionite results in increased expression of CASP3 protein Dithionite results in increased activity of CASP3 protein
CTD
PMID:21803128 PMID:33617922 PMID:34078833
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Dnm1l
dynamin 1-like
multiple interactions
ISO
[[Dithionite results in increased reduction of Paraquat] which co-treated with SLC6A3 protein] results in increased expression of DNM1L protein; [Dithionite results in increased reduction of Paraquat] which results in increased expression of DNM1L protein
CTD
PMID:35511227
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
multiple interactions
EXP
[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein; Genistein inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of GRIA2 protein]
CTD
PMID:27238724
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[dihydroactinidiolide co-treated with Dithionite] results in increased expression of HMOX1 mRNA
CTD
PMID:33617922
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Mir205
microRNA 205
multiple interactions
EXP
[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA]
CTD
PMID:34078833
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
[dihydroactinidiolide co-treated with Dithionite] results in increased expression of NFE2L2 mRNA
CTD
PMID:33617922
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Pink1
PTEN induced kinase 1
multiple interactions
EXP
[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]
CTD
PMID:34078833
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Slc6a3
solute carrier family 6 member 3
multiple interactions
ISO
[[Dithionite results in increased reduction of Paraquat] which co-treated with SLC6A3 protein] results in increased expression of DNM1L protein
CTD
PMID:35511227
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Fast Green FCF inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP
glucoerucin results in increased expression of CYP1A1 protein
CTD
PMID:20833222
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
glucoerucin results in increased expression of CYP1A2 protein
CTD
PMID:20833222
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
EXP
glucoerucin results in increased expression of CYP1B1 protein
CTD
PMID:20833222
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Ephx1
epoxide hydrolase 1
increases expression
EXP
glucoerucin results in increased expression of EPHX1 protein
CTD
PMID:21132492
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases activity
EXP
glucoerucin results in increased activity of NQO1 protein
CTD
PMID:20833222
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Ahr
aryl hydrocarbon receptor
multiple interactions affects binding
ISO
Indigo Carmine binds to and results in increased activity of AHR protein Indigo Carmine binds to AHR protein
CTD
PMID:11425848 PMID:15001395
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
multiple interactions
EXP
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of CHRNA4 protein
CTD
PMID:23429044
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
EXP
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of CHRNB2 protein
CTD
PMID:23429044
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases activity increases expression multiple interactions
ISO EXP
Indigo Carmine results in increased activity of CYP1A1 protein Indigo Carmine results in increased expression of CYP1A1 mRNA Indigo Carmine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
CTD
PMID:15001395 PMID:15882963 PMID:18493746
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
multiple interactions
EXP
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein
CTD
PMID:23429044
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
Indocyanine Green inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Indocyanine Green results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb4
ATP binding cassette subfamily B member 4
affects export
ISO
ABCB4 protein affects the export of Indocyanine Green
CTD
PMID:11302927
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Indocyanine Green results in increased expression of BAX mRNA; Indocyanine Green results in increased expression of BAX protein
CTD
PMID:23675521
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Casp9
caspase 9
increases expression
ISO
Indocyanine Green results in increased expression of CASP9 mRNA; Indocyanine Green results in increased expression of CASP9 protein
CTD
PMID:23675521
Ensembl chr 5:154,109,046...154,126,626
G
Slc10a1
solute carrier family 10 member 1
increases uptake multiple interactions
ISO
SLC10A1 protein results in increased uptake of Indocyanine Green Nifedipine promotes the reaction [SLC10A1 protein results in increased uptake of Indocyanine Green]; Taurocholic Acid inhibits the reaction [SLC10A1 protein results in increased uptake of Indocyanine Green]
CTD
PMID:32209977
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc10a2
solute carrier family 10 member 2
increases uptake
ISO
SLC10A2 protein results in increased uptake of Indocyanine Green
CTD
PMID:32209977
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
G
Slc16a2
solute carrier family 16 member 2
multiple interactions
ISO
Indocyanine Green inhibits the reaction [SLC16A2 protein results in increased uptake of Triiodothyronine]
CTD
PMID:28119167
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
Indocyanine Green inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates]
CTD
PMID:12065749
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
EXP
Indocyanine Green inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
CTD
PMID:10224140
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions increases uptake increases transport
ISO
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Novobiocin inhibits the reaction [ABCG2 protein results in increased uptake of lucifer yellow]; Omeprazole inhibits the reaction [ABCG2 protein results in increased transport of lucifer yellow]
CTD
PMID:31348918 PMID:32305507
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
G
Crh
corticotropin releasing hormone
multiple interactions
EXP
Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [Lipopolysaccharides results in increased secretion of CRH protein]; Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein]
CTD
PMID:11852909
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Egfr
epidermal growth factor receptor
multiple interactions
EXP
Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein]
CTD
PMID:15309881
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Dipyrone inhibits the reaction [IL1B protein results in increased secretion of CRH protein]
CTD
PMID:11852909
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
EXP
Dipyrone inhibits the reaction [IL6 protein results in increased secretion of CRH protein]
CTD
PMID:11852909
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases activity
ISO
Dipyrone analog results in decreased activity of PTGS1 protein; Dipyrone results in decreased activity of PTGS1 protein
CTD
PMID:12242329 PMID:16141368
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Tgfa
transforming growth factor alpha
multiple interactions
EXP
Dipyrone promotes the reaction [Hydrochloric Acid results in increased expression of TGFA protein]
CTD
PMID:15309881
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Dipyrone inhibits the reaction [TNF protein results in increased secretion of CRH protein]
CTD
PMID:11852909
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Txnrd1
thioredoxin reductase 1
increases activity increases expression affects oxidation multiple interactions
ISO
potassium tellurate(IV) results in increased activity of TXNRD1 protein potassium tellurate(IV) results in increased expression of TXNRD1 mRNA potassium tellurate(IV) affects the oxidation of TXNRD1 protein potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]
CTD
PMID:19486940
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases activity
ISO
potassium tellurate(IV) results in increased activity of TXNRD2 protein
CTD
PMID:19486940
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Direct Red 81 inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Abcc9
ATP binding cassette subfamily C member 9
increases expression
EXP
sodium metabisulfite results in increased expression of ABCC9 mRNA; sodium metabisulfite results in increased expression of ABCC9 protein
CTD
PMID:25463229 PMID:26015265
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
sodium metabisulfite results in increased expression of BAX mRNA
CTD
PMID:33957602 PMID:35067933
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
sodium metabisulfite results in decreased expression of BCL2 mRNA
CTD
PMID:33957602 PMID:35067933
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
decreases expression
EXP
sodium metabisulfite results in decreased expression of CACNA1C mRNA; sodium metabisulfite results in decreased expression of CACNA1C protein
CTD
PMID:25463229 PMID:26015265
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
decreases expression
EXP
sodium metabisulfite results in decreased expression of CACNA1D mRNA; sodium metabisulfite results in decreased expression of CACNA1D protein
CTD
PMID:25463229 PMID:26015265
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Casp3
caspase 3
multiple interactions increases activity
EXP ISO
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP3 protein] sodium metabisulfite results in increased expression of and results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:25486021 PMID:33957602
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases expression multiple interactions increases activity
ISO EXP
sodium metabisulfite results in increased expression of CASP8 mRNA GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP8 protein]
CTD
PMID:25486021 PMID:33957602
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases expression multiple interactions increases activity
ISO EXP
sodium metabisulfite results in increased expression of CASP9 mRNA GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP9 protein]
CTD
PMID:25486021 PMID:33957602
Ensembl chr 5:154,109,046...154,126,626
G
Ddit3
DNA-damage inducible transcript 3
increases expression
EXP
sodium metabisulfite results in increased expression of DDIT3 protein
CTD
PMID:25486021
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Ghrl
ghrelin and obestatin prepropeptide
multiple interactions
EXP
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP3 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP8 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of CASP9 protein]; GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of XDH protein]
CTD
PMID:25486021
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
sodium metabisulfite results in increased expression of HSPA5 protein
CTD
PMID:25486021
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
increases expression
EXP
sodium metabisulfite results in increased expression of KCNJ11 mRNA; sodium metabisulfite results in increased expression of KCNJ11 protein
CTD
PMID:25463229 PMID:26015265
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression
EXP
sodium metabisulfite results in increased expression of KCNJ8 mRNA; sodium metabisulfite results in increased expression of KCNJ8 protein
CTD
PMID:25463229
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
increases expression
EXP
sodium metabisulfite results in increased expression of KCNMA1 mRNA; sodium metabisulfite results in increased expression of KCNMA1 protein
CTD
PMID:25463229
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Kcnmb1
potassium calcium-activated channel subfamily M regulatory beta subunit 1
increases expression
EXP
sodium metabisulfite results in increased expression of KCNMB1 mRNA; sodium metabisulfite results in increased expression of KCNMB1 protein
CTD
PMID:25463229
NCBI chr10:18,557,510...18,614,824
Ensembl chr10:18,557,904...18,565,798
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
sodium metabisulfite results in decreased expression of NFKB1 mRNA
CTD
PMID:35067933
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Rela
RELA proto-oncogene, NF-kB subunit
increases phosphorylation
EXP
sodium metabisulfite results in increased phosphorylation of RELA protein
CTD
PMID:25486021
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Scn1a
sodium voltage-gated channel alpha subunit 1
increases expression
EXP
sodium metabisulfite results in increased expression of SCN1A protein
CTD
PMID:29188487
NCBI chr 3:50,952,790...51,071,804
Ensembl chr 3:50,952,791...51,071,699
G
Tp53
tumor protein p53
decreases expression
ISO
sodium metabisulfite results in decreased expression of TP53 mRNA
CTD
PMID:35067933
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Xdh
xanthine dehydrogenase
multiple interactions increases activity
EXP
GHRL protein inhibits the reaction [sodium metabisulfite results in increased activity of XDH protein]
CTD
PMID:25486021
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Aadacl2
arylacetamide deacetylase-like 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of AADACL2 mRNA
CTD
PMID:31734321
NCBI chr 2:144,123,557...144,144,159
G
Abca12
ATP binding cassette subfamily A member 12
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ABCA12 mRNA
CTD
PMID:25377654
NCBI chr 9:72,822,661...72,995,748
Ensembl chr 9:72,823,350...72,996,049
G
Abca6
ATP binding cassette subfamily A member 6
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ABCA6 mRNA
CTD
PMID:20713136
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
G
Abcb6
ATP binding cassette subfamily B member 6
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ABCB6 mRNA
CTD
PMID:31734321
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
G
Abcc1
ATP binding cassette subfamily C member 1
multiple interactions
ISO
Sodium Dodecyl Sulfate inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein]
CTD
PMID:16101123
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ABCC2 mRNA
CTD
PMID:31734321
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ABCC3 mRNA
CTD
PMID:31734321
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Acacb
acetyl-CoA carboxylase beta
affects response to substance
ISO
ACACB SNP affects the susceptibility to Sodium Dodecyl Sulfate
CTD
PMID:27206134
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Ackr3
atypical chemokine receptor 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ACKR3 mRNA
CTD
PMID:31734321
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Adamts3
ADAM metallopeptidase with thrombospondin type 1, motif 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ADAMTS3 mRNA
CTD
PMID:31734321
NCBI chr14:18,231,128...18,437,771
Ensembl chr14:18,231,165...18,435,556
G
Adap2
ArfGAP with dual PH domains 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ADAP2 mRNA
CTD
PMID:31734321
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
G
Adgre5
adhesion G protein-coupled receptor E5
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ADGRE5 mRNA
CTD
PMID:31734321
NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638
G
Adgrg2
adhesion G protein-coupled receptor G2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ADGRG2 mRNA
CTD
PMID:31734321
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
G
Adrb2
adrenoceptor beta 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ADRB2 mRNA
CTD
PMID:31734321
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Adss2
adenylosuccinate synthase 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ADSS2 mRNA
CTD
PMID:31734321
NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604
G
Ahr
aryl hydrocarbon receptor
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of AHR mRNA
CTD
PMID:31734321
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Aif1
allograft inflammatory factor 1
affects response to substance
ISO
AIF1 SNP affects the susceptibility to Sodium Dodecyl Sulfate
CTD
PMID:27258892
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Ak8
adenylate kinase 8
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of AK8 mRNA
CTD
PMID:31734321
NCBI chr 3:12,028,895...12,144,468
Ensembl chr 3:12,028,954...12,144,465
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of AKR1B1 mRNA
CTD
PMID:20566472
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of AKR1B10 mRNA
CTD
PMID:20566472 PMID:30806763
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of AKR1C1 mRNA
CTD
PMID:20566472
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of AKR1C2 mRNA
CTD
PMID:20491607
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression decreases expression
ISO EXP
Sodium Dodecyl Sulfate results in increased expression of AKR1C3 mRNA Sodium Dodecyl Sulfate results in decreased expression of AKR1C3 mRNA Sodium Dodecyl Sulfate results in decreased expression of AKR1C18 mRNA
CTD
PMID:12815608 PMID:20566472 PMID:31734321
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation
ISO
Sodium Dodecyl Sulfate results in increased phosphorylation of AKT1 protein
CTD
PMID:23445166
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aldh3b2
aldehyde dehydrogenase 3 family, member B2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ALDH3B2 mRNA
CTD
PMID:31734321
NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:201,253,157...201,264,705 Ensembl chr 1:201,253,157...201,264,705
G
Aldh3b3
aldehyde dehydrogenase 3 family, member B3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ALDH3B2 mRNA
CTD
PMID:31734321
NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ALOX5AP mRNA
CTD
PMID:31734321
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Angptl4
angiopoietin-like 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ANGPTL4 mRNA
CTD
PMID:31734321
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Ankrd50
ankyrin repeat domain containing 50
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ANKRD50 mRNA
CTD
PMID:31734321
NCBI chr 2:121,466,275...121,500,758
Ensembl chr 2:121,468,573...121,500,752
G
Ap4s1
adaptor related protein complex 4 subunit sigma 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of AP4S1 mRNA
CTD
PMID:31734321
NCBI chr 6:69,133,403...69,174,488
Ensembl chr 6:69,133,373...69,175,496
G
Areg
amphiregulin
increases secretion
ISO
Sodium Dodecyl Sulfate results in increased secretion of AREG protein
CTD
PMID:17763283
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arfgap2
ARF GTPase activating protein 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ARFGAP2 mRNA
CTD
PMID:31734321
NCBI chr 3:77,236,305...77,248,445
Ensembl chr 3:77,236,322...77,248,455
G
Arhgdib
Rho GDP dissociation inhibitor beta
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ARHGDIB mRNA
CTD
PMID:20713136
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
G
Art3
ADP-ribosyltransferase 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ART3 mRNA
CTD
PMID:31734321
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ASNS mRNA
CTD
PMID:31734321
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Aspm
assembly factor for spindle microtubules
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ASPM mRNA
CTD
PMID:31734321
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Asxl1
ASXL transcriptional regulator 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ASXL1 mRNA
CTD
PMID:31734321
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
G
Atf3
activating transcription factor 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ATF3 mRNA
CTD
PMID:23999411
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atg9b
autophagy related 9B
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ATG9B mRNA
CTD
PMID:31734321
NCBI chr 4:10,784,934...10,793,832
Ensembl chr 4:10,786,114...10,793,651
G
Atp12a
ATPase H+/K+ transporting non-gastric alpha2 subunit
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ATP12A mRNA
CTD
PMID:31734321
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
G
Atp5pd
ATP synthase peripheral stalk subunit d
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ATP5PD protein
CTD
PMID:21469165
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
G
B3gat2
beta-1,3-glucuronyltransferase 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of B3GAT2 mRNA
CTD
PMID:31734321
NCBI chr 9:26,167,174...26,250,153
Ensembl chr 9:26,167,174...26,250,153
G
B3gnt3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of B3GNT3 mRNA
CTD
PMID:31734321
NCBI chr16:18,401,405...18,410,821
Ensembl chr16:18,401,405...18,410,766
G
Bambi
BMP and activin membrane-bound inhibitor
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of BAMBI mRNA
CTD
PMID:20146380
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bche
butyrylcholinesterase
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of BCHE mRNA
CTD
PMID:31734321
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bicd1
BICD cargo adaptor 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of BICD1 mRNA
CTD
PMID:31734321
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
G
Blvra
biliverdin reductase A
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of BLVRA protein
CTD
PMID:21469165
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
G
Blvrb
biliverdin reductase B
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of BLVRB mRNA
CTD
PMID:31734321
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Brinp1
BMP/retinoic acid inducible neural specific 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of BRINP1 mRNA
CTD
PMID:31734321
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
G
C18h18orf21
similar to human chromosome 18 open reading frame 21
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of C18ORF21 mRNA
CTD
PMID:31734321
NCBI chr18:15,779,349...15,786,772
Ensembl chr18:15,779,368...15,787,894
G
C19h16orf46
similar to human chromosome 16 open reading frame 46
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of C16ORF46 mRNA
CTD
PMID:31734321
NCBI chr19:45,017,499...45,033,453
Ensembl chr19:45,022,280...45,032,683
G
C1r
complement C1r
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of C1R mRNA
CTD
PMID:31734321
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C2
complement C2
affects response to substance
ISO
C2 SNP affects the susceptibility to Sodium Dodecyl Sulfate
CTD
PMID:27258892
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
G
C2h5orf34
similar to human chromosome 5 open reading frame 34
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of C5ORF34 mRNA
CTD
PMID:31734321
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CAMK2N1 mRNA
CTD
PMID:31734321
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Cant1
calcium activated nucleotidase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CANT1 mRNA
CTD
PMID:31734321
NCBI chr10:103,637,079...103,650,240
Ensembl chr10:103,531,504...103,650,109
G
Capns2
calpain, small subunit 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CAPNS2 mRNA
CTD
PMID:31734321
NCBI chr19:14,104,334...14,105,276
G
Car2
carbonic anhydrase 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CA2 mRNA
CTD
PMID:31734321
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Cbll1
Cbl proto-oncogene like 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CBLL1 mRNA
CTD
PMID:21621594
NCBI chr 6:53,798,712...53,812,890
Ensembl chr 6:48,071,190...48,086,444
G
Ccdc8
coiled-coil domain containing 8
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CCDC8 mRNA
CTD
PMID:31734321
NCBI chr 1:77,679,521...77,682,849
Ensembl chr 1:77,679,218...77,683,090
G
Ccl2
C-C motif chemokine ligand 2
decreases expression multiple interactions
ISO
Sodium Dodecyl Sulfate results in decreased expression of CCL2 mRNA Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
CTD
PMID:20713136 PMID:36416909
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
multiple interactions increases expression increases secretion
ISO
IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein] Sodium Dodecyl Sulfate results in increased expression of CCL20 mRNA
CTD
PMID:15679580 PMID:30806763 PMID:31734321
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl27
C-C motif chemokine ligand 27
increases secretion
ISO
Sodium Dodecyl Sulfate results in increased secretion of CCL27 protein
CTD
PMID:15679580
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein]
CTD
PMID:36416909
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CCL4 mRNA
CTD
PMID:20713136
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
increases secretion increases expression
ISO
Sodium Dodecyl Sulfate results in increased secretion of CCL5 protein Sodium Dodecyl Sulfate results in increased expression of CCL5 mRNA
CTD
PMID:16099135 PMID:31734321
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CCN1 mRNA
CTD
PMID:31734321
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
decreases expression increases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CCN2 mRNA Sodium Dodecyl Sulfate results in increased expression of CCN2 mRNA
CTD
PMID:25377654 PMID:31734321
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccr5
C-C motif chemokine receptor 5
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CCR5 mRNA
CTD
PMID:17936526
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Ccr7
C-C motif chemokine receptor 7
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CCR7 mRNA
CTD
PMID:19371601
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Cd40
CD40 molecule
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CD40 mRNA
CTD
PMID:17936526
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd86
CD86 molecule
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CD86 protein
CTD
PMID:19665512
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdc25a
cell division cycle 25A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CDC25A mRNA
CTD
PMID:31734321
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:109,864,478...109,882,701
G
Cdh26
cadherin 26
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CDH26 mRNA
CTD
PMID:31734321
NCBI chr 3:165,520,523...165,573,191
Ensembl chr 3:165,520,439...165,572,149
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CDKN1C mRNA
CTD
PMID:31734321
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:198,655,407...198,658,048
G
Celf6
CUGBP, Elav-like family member 6
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CELF6 mRNA
CTD
PMID:31734321
NCBI chr 8:59,975,095...60,006,060
Ensembl chr 8:59,975,088...60,005,041
G
Cerk
ceramide kinase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CERK mRNA
CTD
PMID:31734321
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
G
Cers3
ceramide synthase 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CERS3 mRNA
CTD
PMID:29155129 PMID:31734321
NCBI chr 1:129,728,136...129,833,182
Ensembl chr 1:120,318,212...120,422,902
G
Cfl1
cofilin 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CFL1 mRNA; Sodium Dodecyl Sulfate results in increased expression of CFL1 protein
CTD
PMID:21469165
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CHAC1 mRNA
CTD
PMID:31734321
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Chst11
carbohydrate sulfotransferase 11
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CHST11 mRNA
CTD
PMID:31734321
NCBI chr 7:20,524,535...20,743,008
Ensembl chr 7:20,528,100...20,743,111
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CITED2 mRNA
CTD
PMID:31734321
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Clcf1
cardiotrophin-like cytokine factor 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CLCF1 mRNA
CTD
PMID:31734321
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
G
Cldn7
claudin 7
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CLDN7 mRNA
CTD
PMID:31734321
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
G
Clk3
CDC-like kinase 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CLK3 mRNA
CTD
PMID:31734321
NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
G
Clmn
calmin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CLMN mRNA
CTD
PMID:31734321
NCBI chr 6:123,707,710...123,807,283
Ensembl chr 6:123,713,507...123,807,272
G
Cmklr2
chemerin chemokine-like receptor 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CMKLR2 mRNA
CTD
PMID:31734321
NCBI chr 9:64,583,310...64,617,883
Ensembl chr 9:64,585,594...64,586,655
G
Cmtm8
CKLF-like MARVEL transmembrane domain containing 8
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CMTM8 mRNA
CTD
PMID:31734321
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
G
Cnfn
cornifelin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CNFN mRNA; Sodium Dodecyl Sulfate results in increased expression of CNFN protein
CTD
PMID:25377654
NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747
G
Cnnm2
cyclin and CBS domain divalent metal cation transport mediator 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CNNM2 mRNA
CTD
PMID:31734321
NCBI chr 1:245,643,682...245,769,542
Ensembl chr 1:245,643,768...245,763,286
G
Col11a1
collagen type XI alpha 1 chain
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of COL11A1 mRNA
CTD
PMID:31734321
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
G
Col2a1
collagen type II alpha 1 chain
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of COL2A1 mRNA
CTD
PMID:31734321
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Cox19
cytochrome c oxidase assembly factor COX19
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of COX19 mRNA
CTD
PMID:31734321
NCBI chr12:15,303,535...15,313,014
Ensembl chr12:15,303,551...15,313,014
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CPT1A mRNA
CTD
PMID:31734321
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Crabp2
cellular retinoic acid binding protein 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CRABP2 mRNA
CTD
PMID:31734321
NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:173,416,857...173,421,379
G
Crct1
cysteine-rich C-terminal 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CRCT1 mRNA
CTD
PMID:31734321
NCBI chr 2:178,633,789...178,635,274
Ensembl chr 2:178,634,092...178,634,394
G
Creb1
cAMP responsive element binding protein 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CREB1 mRNA
CTD
PMID:20385217
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crebbp
CREB binding protein
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CREBBP mRNA
CTD
PMID:31734321
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Creld2
cysteine-rich with EGF-like domains 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CRELD2 mRNA
CTD
PMID:31734321
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
G
Crnn
cornulin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CRNN mRNA
CTD
PMID:25240866
NCBI chr 2:178,733,329...178,736,404
Ensembl chr 2:178,731,796...178,736,216
G
Crtam
cytotoxic and regulatory T cell molecule
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CRTAM mRNA
CTD
PMID:31734321
NCBI chr 8:41,340,117...41,377,381
Ensembl chr 8:41,340,837...41,377,343
G
Csf2
colony stimulating factor 2
increases expression increases secretion
ISO
Sodium Dodecyl Sulfate results in increased expression of CSF2 mRNA Sodium Dodecyl Sulfate results in increased secretion of CSF2 protein
CTD
PMID:11378323 PMID:22245253
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf2rb
colony stimulating factor 2 receptor subunit beta
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CSF2RB mRNA
CTD
PMID:31734321
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
G
Csrnp1
cysteine and serine rich nuclear protein 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CSRNP1 mRNA
CTD
PMID:31734321
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Ctdnep1
CTD nuclear envelope phosphatase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CTDNEP1 mRNA
CTD
PMID:31734321
NCBI chr10:54,704,367...54,713,781
Ensembl chr10:54,704,148...54,713,781
G
Ctsh
cathepsin H
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CTSH mRNA
CTD
PMID:31734321
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
G
Cul7
cullin 7
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CUL7 mRNA
CTD
PMID:31734321
NCBI chr 9:14,319,102...14,333,035
Ensembl chr 9:14,319,108...14,332,741
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CXCL1 mRNA
CTD
PMID:31734321
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CXCL10 mRNA
CTD
PMID:17936526 PMID:23445166 PMID:31734321
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl14
C-X-C motif chemokine ligand 14
decreases expression multiple interactions
ISO
Sodium Dodecyl Sulfate results in decreased expression of CXCL14 mRNA; Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein]; WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in decreased expression of CXCL14 protein]
CTD
PMID:31734321
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
G
Cxcl2
C-X-C motif chemokine ligand 2
decreases expression increases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CXCL2 protein Sodium Dodecyl Sulfate results in increased expression of CXCL2 protein
CTD
PMID:23178550
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CXCL1 mRNA
CTD
PMID:28826779 PMID:31734321
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CXCR4 mRNA
CTD
PMID:20713136
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyb561a3
cytochrome b561 family, member A3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CYB561A3 mRNA
CTD
PMID:31734321
NCBI chr 1:207,216,185...207,237,575
Ensembl chr 1:207,226,230...207,237,571
G
Cyb5r4
cytochrome b5 reductase 4
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CYB5R4 mRNA
CTD
PMID:31734321
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of CYP1A1 mRNA
CTD
PMID:20491607 PMID:30806763
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of CYP27A1 mRNA
CTD
PMID:12815608
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of CYP2B2 mRNA
CTD
PMID:12815608
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp4f1
cytochrome P450, family 4, subfamily f, polypeptide 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of CYP4F12 mRNA
CTD
PMID:31734321
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
G
Cyp51
cytochrome P450, family 51
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of CYP51 mRNA
CTD
PMID:12815608
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
G
Dapl1
death associated protein-like 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DAPL1 mRNA
CTD
PMID:31734321
NCBI chr 3:43,960,993...43,980,940
Ensembl chr 3:43,960,810...43,980,940
G
Dcxr
dicarbonyl and L-xylulose reductase
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DCXR mRNA
CTD
PMID:31734321
NCBI chr10:106,006,404...106,008,293
G
Ddit3
DNA-damage inducible transcript 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DDIT3 mRNA
CTD
PMID:31734321
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Ddx60
DEXD/H-box helicase 60
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DDX60 mRNA
CTD
PMID:31734321
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Degs1
delta(4)-desaturase, sphingolipid 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DEGS1 mRNA
CTD
PMID:31734321
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
G
Dennd2d
DENN domain containing 2D
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DENND2D mRNA
CTD
PMID:31734321
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
G
Dffb
DNA fragmentation factor subunit beta
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DFFB mRNA
CTD
PMID:31734321
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dhcr7
7-dehydrocholesterol reductase
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of DHCR7 mRNA
CTD
PMID:12815608
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dhdh
dihydrodiol dehydrogenase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DHDH mRNA
CTD
PMID:31734321
NCBI chr 1:95,954,361...95,965,262
Ensembl chr 1:95,953,092...95,965,197
G
Dip2c
disco-interacting protein 2 homolog C
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DIP2C mRNA
CTD
PMID:31734321
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DNAJB4 mRNA
CTD
PMID:23999411
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dok7
docking protein 7
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DOK7 mRNA
CTD
PMID:31734321
NCBI chr14:75,665,444...75,699,413
Ensembl chr14:75,666,744...75,699,386
G
Dpysl2
dihydropyrimidinase-like 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DPYSL2 mRNA
CTD
PMID:31734321
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:41,005,551...41,111,829
G
Dsc1
desmocollin 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DSC1 mRNA
CTD
PMID:31734321
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
G
Dsg1
desmoglein 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of DSG1 mRNA
CTD
PMID:31734321
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DUSP1 mRNA
CTD
PMID:30806763
NCBI chr10:16,680,478...16,683,275
G
Dusp2
dual specificity phosphatase 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of DUSP2 mRNA
CTD
PMID:31734321
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
E2f8
E2F transcription factor 8
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of E2F8 mRNA
CTD
PMID:31734321
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Edn1
endothelin 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of EDN1 mRNA
CTD
PMID:31734321
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of EFEMP2 mRNA
CTD
PMID:31734321
NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:202,781,665...202,789,414
G
Egr1
early growth response 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of EGR1 mRNA
CTD
PMID:25377654 PMID:31734321
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif2ak1
eukaryotic translation initiation factor 2 alpha kinase 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of EIF2AK1 mRNA
CTD
PMID:31734321
NCBI chr12:10,710,771...10,744,597
Ensembl chr12:10,705,874...10,744,573
G
Elovl1
ELOVL fatty acid elongase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ELOVL1 mRNA
CTD
PMID:29155129
NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:131,961,322...131,965,958
G
Emp1
epithelial membrane protein 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of EMP1 mRNA
CTD
PMID:31734321
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
G
Ermap
erythroblast membrane associated protein (Scianna blood group)
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ERMAP mRNA
CTD
PMID:31734321
NCBI chr 5:132,788,847...132,803,030
Ensembl chr 5:132,789,991...132,802,847
G
Ezr
ezrin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of EZR mRNA; Sodium Dodecyl Sulfate results in increased expression of EZR protein
CTD
PMID:29893927
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F8
coagulation factor VIII
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of F8 mRNA
CTD
PMID:31734321
NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857
G
Fabp3
fatty acid binding protein 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FABP3 mRNA
CTD
PMID:31734321
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
G
Fabp4
fatty acid binding protein 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FABP4 mRNA
CTD
PMID:30806763
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fah
fumarylacetoacetate hydrolase
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FAH mRNA
CTD
PMID:31734321
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fam171a1
family with sequence similarity 171, member A1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FAM171A1 mRNA
CTD
PMID:31734321
NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255
G
Fam83c
family with sequence similarity 83, member C
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FAM83C mRNA
CTD
PMID:31734321
NCBI chr 3:144,333,736...144,339,758
Ensembl chr 3:144,332,982...144,339,802
G
Fancl
FA complementation group L
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FANCL mRNA
CTD
PMID:31734321
NCBI chr14:104,449,403...104,515,297
Ensembl chr14:100,248,875...100,314,255
G
Fbxo5
F-box protein 5
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FBXO5 mRNA
CTD
PMID:31734321
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fech
ferrochelatase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FECH mRNA
CTD
PMID:20566472
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
G
Fkbp11
FKBP prolyl isomerase 11
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FKBP11 mRNA
CTD
PMID:31734321
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
G
Flg
filaggrin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FLG mRNA; Sodium Dodecyl Sulfate results in increased expression of FLG protein
CTD
PMID:25240866
NCBI chr 2:178,884,793...178,912,986
G
Flg2
filaggrin 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FLG2 mRNA
CTD
PMID:25240866
NCBI chr 2:178,789,792...178,802,232
G
Fn1
fibronectin 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FN1 mRNA
CTD
PMID:25377654
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
EXP ISO
Sodium Dodecyl Sulfate results in decreased expression of FOS mRNA Sodium Dodecyl Sulfate results in increased expression of FOS mRNA
CTD
PMID:12815608 PMID:31734321
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxa2
forkhead box A2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FOXA2 mRNA
CTD
PMID:31734321
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Foxn1
forkhead box N1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FOXN1 mRNA
CTD
PMID:31734321
NCBI chr10:63,251,400...63,273,710
Ensembl chr10:63,251,400...63,273,710
G
Foxo4
forkhead box O4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FOXO4 mRNA
CTD
PMID:31734321
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
G
Fst
follistatin
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FST mRNA
CTD
PMID:31734321
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
G
Ftl1
ferritin light chain 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of FTL mRNA
CTD
PMID:20566472
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
Fzd7
frizzled class receptor 7
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of FZD7 mRNA
CTD
PMID:31734321
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
G0s2
G0/G1switch 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of G0S2 mRNA
CTD
PMID:31734321
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of G6PD mRNA
CTD
PMID:20566472
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GADD45B mRNA
CTD
PMID:31734321
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gal
galanin and GMAP prepropeptide
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GAL mRNA
CTD
PMID:31734321
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of GAPDH mRNA
CTD
PMID:12815608
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gas2l3
growth arrest-specific 2 like 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GAS2L3 mRNA
CTD
PMID:31734321
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
G
Gast
gastrin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GAST mRNA
CTD
PMID:31734321
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
G
Gbp1
guanylate binding protein 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of GBP1 mRNA
CTD
PMID:21621594
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GCLC mRNA
CTD
PMID:20566472
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GCLM mRNA
CTD
PMID:20566472
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gem
GTP binding protein overexpressed in skeletal muscle
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GEM mRNA
CTD
PMID:31734321
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
G
Gja1
gap junction protein, alpha 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of GJA1 mRNA
CTD
PMID:31734321
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gjb1
gap junction protein, beta 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of GJB1 mRNA
CTD
PMID:21621594
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Gjb2
gap junction protein, beta 2
increases expression
EXP
Sodium Dodecyl Sulfate results in increased expression of GJB2 mRNA
CTD
PMID:12815608
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gjb6
gap junction protein, beta 6
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of GJB6 mRNA
CTD
PMID:31734321
NCBI chr15:31,284,561...31,294,552
Ensembl chr15:31,284,419...31,294,582
G
Gjc1
gap junction protein, gamma 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GJC1 mRNA
CTD
PMID:31734321
NCBI chr10:87,758,192...87,785,443
Ensembl chr10:87,760,528...87,785,867
G
Gldc
glycine decarboxylase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GLDC mRNA
CTD
PMID:31734321
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
G
Gpatch11
G patch domain containing 11
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of GPATCH11 mRNA
CTD
PMID:31734321
NCBI chr 6:16,229,933...16,243,305
Ensembl chr 6:16,233,059...16,243,238
G
Grb7
growth factor receptor bound protein 7
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GRB7 mRNA
CTD
PMID:31734321
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
G
Grhl1
grainyhead-like transcription factor 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of GRHL1 mRNA
CTD
PMID:31734321
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of GSR mRNA
CTD
PMID:20566472
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Has3
hyaluronan synthase 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of HAS3 mRNA
CTD
PMID:31734321
NCBI chr19:34,768,421...34,782,170
Ensembl chr19:34,771,982...34,782,592
G
Hcls1
hematopoietic cell specific Lyn substrate 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HCLS1 mRNA
CTD
PMID:31734321
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
G
Herc6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of HERC6 mRNA
CTD
PMID:31734321
NCBI chr 4:88,854,612...88,897,043
Ensembl chr 4:87,524,493...87,581,744
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HEY1 mRNA
CTD
PMID:31734321
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
G
Hist1h2af
histone cluster 1 H2A family member F
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of H2AC8 mRNA
CTD
PMID:31734321
NCBI chr17:41,807,261...41,807,653
Ensembl chr17:41,379,404...41,379,796
G
Hist1h2bc
histone cluster 1, H2bc
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of H2BC21 mRNA
CTD
PMID:31734321
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
G
Hist2h2be
histone cluster 2 H2B family member E
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of H2BC11 mRNA
CTD
PMID:31734321
NCBI chr 2:183,780,583...183,783,030
G
Hk2
hexokinase 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of HK2 mRNA
CTD
PMID:31734321
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Hmox1
heme oxygenase 1
increases expression affects expression
ISO EXP
Sodium Dodecyl Sulfate results in increased expression of HMOX1 mRNA Sodium Dodecyl Sulfate affects the expression of HMOX1 mRNA
CTD
PMID:12815608 PMID:20566472 PMID:22954530 PMID:30806763 PMID:31734321
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmox2
heme oxygenase 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HMOX2 mRNA
CTD
PMID:31734321
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of HNRNPAB protein
CTD
PMID:21469165
NCBI chr10:36,358,004...36,363,898
Ensembl chr10:35,857,041...35,863,344
G
Hnrnpll
heterogeneous nuclear ribonucleoprotein L-like
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of HNRNPLL mRNA
CTD
PMID:31734321
NCBI chr 6:14,969,953...15,000,574
Ensembl chr 6:14,970,057...14,999,745
G
Hpcal1
hippocalcin-like 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HPCAL1 mRNA
CTD
PMID:31734321
NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687
G
Hs3st2
heparan sulfate-glucosamine 3-sulfotransferase 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HS3ST2 mRNA
CTD
PMID:31734321
NCBI chr 1:175,956,161...176,077,400
Ensembl chr 1:175,956,157...176,077,399
G
Hscb
HscB mitochondrial iron-sulfur cluster co-chaperone
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of HSCB mRNA
CTD
PMID:31734321
NCBI chr12:45,821,527...45,831,902
Ensembl chr12:45,821,555...45,831,909
G
Hsfx3l
heat shock transcription factor family, X-linked member 3 like
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HSFX3 mRNA
CTD
PMID:31734321
NCBI chr X:146,126,163...146,128,629
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HSPA6 mRNA
CTD
PMID:23999411
NCBI chr13:83,273,176...83,274,317
G
Hspb1
heat shock protein family B (small) member 1
decreases expression multiple interactions increases expression decreases phosphorylation
EXP ISO
Sodium Dodecyl Sulfate results in decreased expression of HSPB1 mRNA Sodium Dodecyl Sulfate results in decreased expression of and affects the localization of HSPB1 protein Sodium Dodecyl Sulfate results in increased expression of HSPB1 mRNA; Sodium Dodecyl Sulfate results in increased expression of HSPB1 protein Sodium Dodecyl Sulfate results in decreased phosphorylation of HSPB1 protein
CTD
PMID:12815608 PMID:20332019 PMID:21469165
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HSPB8 mRNA
CTD
PMID:31734321
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of HSPH1 mRNA
CTD
PMID:23999411
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Ibtk
inhibitor of Bruton tyrosine kinase
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of IBTK mRNA
CTD
PMID:31734321
NCBI chr 8:86,625,591...86,698,661
Ensembl chr 8:86,625,597...86,698,260
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ICAM1 mRNA
CTD
PMID:11378323
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Idh3a
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of IDH3A protein
CTD
PMID:21469165
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of IDI1 protein
CTD
PMID:21469165
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ifi35
interferon-induced protein 35
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of IFI35 mRNA
CTD
PMID:31734321
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifng
interferon gamma
multiple interactions increases expression
ISO
[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein Sodium Dodecyl Sulfate results in increased expression of IFNG protein
CTD
PMID:12062936 PMID:28826779
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf2r
insulin-like growth factor 2 receptor
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IGF2R mRNA
CTD
PMID:31734321
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Il12b
interleukin 12B
multiple interactions
ISO
Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]
CTD
PMID:36416909
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il13ra2
interleukin 13 receptor subunit alpha 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL13RA2 mRNA
CTD
PMID:31734321
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il16
interleukin 16
increases secretion
ISO
Sodium Dodecyl Sulfate results in increased secretion of IL16 protein
CTD
PMID:30806763
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
G
Il17a
interleukin 17A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL17A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL17A protein
CTD
PMID:28826779
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il1a
interleukin 1 alpha
multiple interactions decreases expression increases expression increases secretion
ISO
IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; IL1A protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein]; Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of IL1A protein Sodium Dodecyl Sulfate results in decreased expression of IL1A protein Sodium Dodecyl Sulfate results in increased expression of IL1A mRNA; Sodium Dodecyl Sulfate results in increased expression of IL1A protein Sodium Dodecyl Sulfate results in increased secretion of IL1A protein
CTD
PMID:11378323 PMID:12781210 PMID:15679580 PMID:19878710 PMID:21469165 PMID:25290854 PMID:33839235 More...
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL1B mRNA
CTD
PMID:9856837 PMID:11378323 PMID:33715048
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL1R2 mRNA
CTD
PMID:30806763
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il1rl1
interleukin 1 receptor-like 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL1RL1 mRNA
CTD
PMID:31734321
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il2
interleukin 2
multiple interactions increases expression
ISO
[Sodium Dodecyl Sulfate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 protein Sodium Dodecyl Sulfate results in increased expression of IL2 protein
CTD
PMID:15588918 PMID:22381623
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il24
interleukin 24
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL24 protein
CTD
PMID:25168428
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il33
interleukin 33
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of IL33 mRNA
CTD
PMID:31734321
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il36g
interleukin 36, gamma
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL36G mRNA
CTD
PMID:31734321
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
G
Il36rn
interleukin 36 receptor antagonist
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL36RN mRNA
CTD
PMID:31734321
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
G
Il4
interleukin 4
multiple interactions increases expression
ISO
[dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein; [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IL4 protein Sodium Dodecyl Sulfate results in increased expression of IL4 mRNA
CTD
PMID:12062936 PMID:28826779
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
increases expression multiple interactions
ISO
Sodium Dodecyl Sulfate results in increased expression of IL6 mRNA; Sodium Dodecyl Sulfate results in increased expression of IL6 protein [Tetradecanoylphorbol Acetate co-treated with Sodium Dodecyl Sulfate] results in increased expression of and results in increased secretion of IL6 protein
CTD
PMID:11378323 PMID:24964617 PMID:33839235
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7r
interleukin 7 receptor
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IL7R mRNA
CTD
PMID:20713136
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Impdh2
inosine monophosphate dehydrogenase 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of IMPDH2 mRNA
CTD
PMID:31734321
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
G
Irag1
inositol 1,4,5-triphosphate receptor associated 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IRAG1 mRNA
CTD
PMID:31734321
NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
G
Irx3
iroquois homeobox 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of IRX3 mRNA
CTD
PMID:31734321
NCBI chr19:15,211,882...15,215,317
Ensembl chr19:15,211,878...15,215,317
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ITPR1 mRNA
CTD
PMID:31734321
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
G
Ivl
involucrin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of IVL mRNA; Sodium Dodecyl Sulfate results in increased expression of IVL protein
CTD
PMID:25240866
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Sodium Dodecyl Sulfate inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Jph2
junctophilin 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of JPH2 mRNA
CTD
PMID:31734321
NCBI chr 3:151,994,768...152,058,941
Ensembl chr 3:151,994,778...152,058,904
G
Jpx
JPX transcript, XIST activator
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of JPX mRNA
CTD
PMID:31734321
NCBI chr X:68,511,491...68,665,132
G
Jrk
Jrk helix-turn-helix protein
affects expression
ISO
Sodium Dodecyl Sulfate affects the expression of JRK mRNA
CTD
PMID:31734321
NCBI chr 7:106,590,662...106,595,345
Ensembl chr 7:106,589,484...106,596,371
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of JUNB mRNA
CTD
PMID:31734321
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Kctd11
potassium channel tetramerization domain containing 11
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KCTD11 mRNA
CTD
PMID:31734321
NCBI chr10:54,602,575...54,604,738
Ensembl chr10:54,599,754...54,604,760
G
Kiaa1549
KIAA1549 homolog
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of KIAA1549 mRNA
CTD
PMID:31734321
NCBI chr 4:66,840,674...66,968,407
Ensembl chr 4:66,760,162...66,968,436
G
Kiaa1958
KIAA1958 homolog
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of KIAA1958 mRNA
CTD
PMID:31734321
NCBI chr 5:74,491,762...74,637,929
Ensembl chr 5:74,491,752...74,632,408
G
Kif20b
kinesin family member 20B
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KIF20B mRNA
CTD
PMID:31734321
NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:232,428,371...232,483,787
G
Klc2
kinesin light chain 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of KLC2 mRNA
CTD
PMID:31734321
NCBI chr 1:202,414,555...202,424,787
Ensembl chr 1:202,414,557...202,424,672
G
Klhl21
kelch-like family member 21
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of KLHL21 mRNA
CTD
PMID:31734321
NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:162,514,765...162,523,545
G
Klk10
kallikrein related-peptidase 10
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KLK10 mRNA
CTD
PMID:31734321
NCBI chr 1:94,234,536...94,239,369
Ensembl chr 1:94,235,096...94,239,376
G
Klrg2
killer cell lectin like receptor G2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KLRG2 mRNA
CTD
PMID:31734321
NCBI chr 4:67,360,216...67,374,867
Ensembl chr 4:67,363,919...67,374,147
G
Kng1
kininogen 1
increases expression
EXP
Sodium Dodecyl Sulfate results in increased expression of KNG1 mRNA
CTD
PMID:12815608
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Krt1
keratin 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KRT1 mRNA
CTD
PMID:31734321
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
G
Krt18
keratin 18
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of KRT18 mRNA
CTD
PMID:31734321
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
G
Krt2
keratin 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of KRT2 mRNA
CTD
PMID:31734321
NCBI chr 7:132,940,879...132,948,031
Ensembl chr 7:132,940,862...132,947,963
G
Krt8
keratin 8
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KRT8 mRNA
CTD
PMID:21621594
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Krt80
keratin 80
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KRT80 mRNA
CTD
PMID:31734321
NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508
G
Krt9
keratin 9
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of KRT9 protein
CTD
PMID:21469165
NCBI chr10:85,120,962...85,127,228
Ensembl chr10:85,122,424...85,127,228
G
Lamb1
laminin subunit beta 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LAMB1 mRNA
CTD
PMID:31734321
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
G
Lamp3
lysosomal-associated membrane protein 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LAMP3 mRNA
CTD
PMID:31734321
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
G
Lce1e
late cornified envelope 1E
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of LCE1E mRNA
CTD
PMID:25240866
NCBI chr 2:178,462,100...178,463,433
Ensembl chr 2:178,462,100...178,463,433
G
Lcn2
lipocalin 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of LCN2 mRNA
CTD
PMID:31734321
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Ldlrad3
low density lipoprotein receptor class A domain containing 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LDLRAD3 mRNA
CTD
PMID:31734321
NCBI chr 3:88,239,529...88,481,340
Ensembl chr 3:88,239,622...88,481,267
G
Lemd1
LEM domain containing 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LEMD1 mRNA
CTD
PMID:31734321
NCBI chr13:43,631,705...43,697,765
Ensembl chr13:43,665,926...43,697,948
G
Lias
lipoic acid synthetase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of LIAS mRNA
CTD
PMID:21621594
NCBI chr14:42,876,699...42,893,824
Ensembl chr14:42,876,699...42,893,783
G
Lif
LIF, interleukin 6 family cytokine
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LIF protein
CTD
PMID:19878710
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lig3
DNA ligase 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of LIG3 mRNA
CTD
PMID:31734321
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
G
LOC100912195
protein BEX1-like
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of BEX5 mRNA
CTD
PMID:31734321
NCBI chr 1:110,047,861...110,051,812
G
Loricrin
loricrin cornified envelope precursor protein
decreases expression increases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LORICRIN protein Sodium Dodecyl Sulfate results in increased expression of LORICRIN mRNA
CTD
PMID:25240866 PMID:33839235
NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807
G
Lrrc8e
leucine rich repeat containing 8 VRAC subunit E
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of LRRC8E mRNA
CTD
PMID:31734321
NCBI chr12:2,578,240...2,589,407
Ensembl chr12:2,578,315...2,589,412
G
Ltf
lactotransferrin
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LTF mRNA
CTD
PMID:21621594
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of LYN mRNA
CTD
PMID:31734321
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
G
Lypla1
lysophospholipase 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of LYPLA1 protein
CTD
PMID:21469165
NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:14,679,606...14,708,746
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MAFF mRNA
CTD
PMID:20491607
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MAFG mRNA
CTD
PMID:20566472
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
G
Mageh1
MAGE family member H1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MAGEH1 mRNA
CTD
PMID:31734321
NCBI chr X:18,350,015...18,351,271
Ensembl chr X:18,349,774...18,351,516
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of MAP3K1 mRNA
CTD
PMID:12815608
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:43,350,098...43,414,463
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MAP3K8 mRNA
CTD
PMID:31734321
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
ISO
Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK1 protein]
CTD
PMID:31734321
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
increases phosphorylation
ISO
Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK14 protein
CTD
PMID:15737199
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions
ISO
Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of MAPK3 protein]
CTD
PMID:31734321
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Marcksl1
MARCKS-like 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MARCKSL1 mRNA
CTD
PMID:31734321
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
G
Mblac1
metallo-beta-lactamase domain containing 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MBLAC1 mRNA
CTD
PMID:31734321
NCBI chr12:17,071,465...17,072,736
Ensembl chr12:17,071,465...17,072,735
G
Mctp1
multiple C2 and transmembrane domain containing 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MCTP1 mRNA
CTD
PMID:31734321
NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833
G
Me1
malic enzyme 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ME1 mRNA
CTD
PMID:20566472
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
Meox1
mesenchyme homeobox 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MEOX1 mRNA
CTD
PMID:31734321
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Micb
MHC class I polypeptide-related sequence B
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MICB mRNA
CTD
PMID:31734321
NCBI chr 1:78,495,779...78,513,030
Ensembl chr 1:78,495,779...78,512,827
G
Mir205
microRNA 205
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of MIR205 mRNA
CTD
PMID:31734321
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
G
Mmaa
metabolism of cobalamin associated A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MMAA mRNA
CTD
PMID:31734321
NCBI chr19:28,619,060...28,649,319
Ensembl chr19:28,619,087...28,649,319
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MMP10 mRNA
CTD
PMID:30806763 PMID:31734321
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp3
matrix metallopeptidase 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MMP3 mRNA
CTD
PMID:30806763
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mosmo
modulator of smoothened
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of MOSMO mRNA
CTD
PMID:31734321
NCBI chr 1:175,217,680...175,288,521
Ensembl chr 1:175,217,545...175,288,334
G
Mrpl38
mitochondrial ribosomal protein L38
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of MRPL38 mRNA
CTD
PMID:31734321
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
G
Msrb2
methionine sulfoxide reductase B2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of MSRB2 mRNA
CTD
PMID:31734321
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
G
Mt1
metallothionein 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MT1A mRNA
CTD
PMID:20491607
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2
metallothionein 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MT2A mRNA
CTD
PMID:31734321
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Muc15
mucin 15, cell surface associated
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of MUC15 mRNA
CTD
PMID:31734321
NCBI chr 3:97,294,728...97,308,641
Ensembl chr 3:97,294,783...97,307,090
G
Mxd1
max dimerization protein 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MXD1 mRNA
CTD
PMID:20713136
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:119,097,353...119,117,751
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
Sodium Dodecyl Sulfate results in increased expression of MYC mRNA
CTD
PMID:12815608
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Myef2
myelin expression factor 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MYEF2 mRNA
CTD
PMID:31734321
NCBI chr 3:112,338,241...112,374,122
Ensembl chr 3:112,338,241...112,374,181
G
Myl12a
myosin light chain 12A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of MYL12A mRNA
CTD
PMID:31734321
NCBI chr 9:110,891,970...110,899,655
Ensembl chr 9:110,873,959...110,916,580
G
Nexn
nexilin (F actin binding protein)
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of NEXN mRNA
CTD
PMID:31734321
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
G
Nfkb1
nuclear factor kappa B subunit 1
affects expression
ISO
Sodium Dodecyl Sulfate affects the expression of NFKB1 mRNA
CTD
PMID:20385217
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfya
nuclear transcription factor Y subunit alpha
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of NFYA mRNA
CTD
PMID:31734321
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
G
Nipsnap2
nipsnap homolog 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of NIPSNAP2 mRNA
CTD
PMID:31734321
NCBI chr12:26,906,068...26,944,201
Ensembl chr12:26,911,723...26,944,166
G
Nlrp10
NLR family, pyrin domain containing 10
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of NLRP10 mRNA
CTD
PMID:31734321
NCBI chr 1:162,922,806...162,930,363
Ensembl chr 1:162,922,806...162,930,363
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of NME2 protein
CTD
PMID:21469165
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
G
Nmu
neuromedin U
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of NMU mRNA
CTD
PMID:31734321
NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of NQO1 mRNA
CTD
PMID:20491607 PMID:20566472
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of NR4A2 mRNA
CTD
PMID:25377654
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
affects response to substance
ISO
NTRK2 SNP affects the susceptibility to Sodium Dodecyl Sulfate
CTD
PMID:27206134
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Olfml2a
olfactomedin-like 2A
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of OLFML2A mRNA
CTD
PMID:31734321
NCBI chr 3:43,098,299...43,127,621
Ensembl chr 3:22,688,598...22,717,909
G
P2ry1
purinergic receptor P2Y1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of P2RY1 mRNA
CTD
PMID:31734321
NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457
G
Pask
PAS domain containing serine/threonine kinase
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of PASK mRNA
CTD
PMID:12815608
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pced1a
PC-esterase domain containing 1A
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PCED1A mRNA
CTD
PMID:31734321
NCBI chr 3:117,600,958...117,622,992
Ensembl chr 3:117,616,921...117,622,962
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PCK2 mRNA
CTD
PMID:31734321
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pcsk6
proprotein convertase subtilisin/kexin type 6
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PCSK6 mRNA
CTD
PMID:31734321
NCBI chr 1:128,839,742...129,038,087
Ensembl chr 1:119,429,265...119,627,596
G
Pctp
phosphatidylcholine transfer protein
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PCTP mRNA
CTD
PMID:31734321
NCBI chr10:74,808,887...74,856,260
Ensembl chr10:74,808,887...74,849,867
G
Pdha1
pyruvate dehydrogenase E1 subunit alpha 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PDHA1 protein
CTD
PMID:21469165
NCBI chr X:34,700,481...34,714,309
Ensembl chr X:34,700,409...34,714,311
G
Per2
period circadian regulator 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PER2 mRNA
CTD
PMID:31734321
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
G
Pex11g
peroxisomal biogenesis factor 11 gamma
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PEX11G mRNA
CTD
PMID:31734321
NCBI chr12:1,502,606...1,532,347
Ensembl chr12:1,503,646...1,512,585
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PGD mRNA
CTD
PMID:20566472
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Pheta1
PH domain containing endocytic trafficking adaptor 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PHETA1 mRNA
CTD
PMID:31734321
NCBI chr12:34,711,831...34,717,601
Ensembl chr12:34,711,810...34,717,081
G
Phtf1
putative homeodomain transcription factor 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PHTF1 mRNA
CTD
PMID:31734321
NCBI chr 2:191,470,849...191,537,399
Ensembl chr 2:191,473,130...191,512,078
G
Pip4k2b
phosphatidylinositol-5-phosphate 4-kinase type 2 beta
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PIP4K2B mRNA
CTD
PMID:31734321
NCBI chr10:82,706,016...82,734,938
Ensembl chr10:82,701,098...82,734,938
G
Pir
pirin
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PIR mRNA
CTD
PMID:31734321
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pitpnb
phosphatidylinositol transfer protein, beta
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PITPNB protein
CTD
PMID:21469165
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
G
Piwil2
piwi-like RNA-mediated gene silencing 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PIWIL2 mRNA
CTD
PMID:31734321
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
G
Pjvk
pejvakin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PJVK mRNA
CTD
PMID:31734321
NCBI chr 3:61,594,644...61,605,051
Ensembl chr 3:61,596,641...61,605,045
G
Pla2g4a
phospholipase A2 group 4A
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PLA2G4A mRNA
CTD
PMID:31734321
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266
G
Plaur
plasminogen activator, urokinase receptor
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PLAUR mRNA
CTD
PMID:31734321
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Pld1
phospholipase D1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PLD1 mRNA
CTD
PMID:31734321
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
G
Plekhb1
pleckstrin homology domain containing B1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PLEKHB1 mRNA
CTD
PMID:31734321
NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142
G
Plekhg1
pleckstrin homology and RhoGEF domain containing G1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PLEKHG1 mRNA
CTD
PMID:31734321
NCBI chr 1:40,348,684...40,434,063
Ensembl chr 1:40,311,221...40,434,063
G
Plgrkt
plasminogen receptor with a C-terminal lysine
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PLGRKT mRNA
CTD
PMID:31734321
NCBI chr 1:227,099,005...227,111,277
Ensembl chr 1:227,099,015...227,111,194
G
Plk3
polo-like kinase 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PLK3 mRNA
CTD
PMID:31734321
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Plpp3
phospholipid phosphatase 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PLPP3 mRNA
CTD
PMID:31734321
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Plxnc1
plexin C1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PLXNC1 mRNA
CTD
PMID:31734321
NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779
G
Pnpla6
patatin-like phospholipase domain containing 6
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PNPLA6 mRNA
CTD
PMID:31734321
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Ppfibp2
PPFIA binding protein 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PPFIBP2 mRNA
CTD
PMID:31734321
NCBI chr 1:161,504,774...161,687,339
Ensembl chr 1:161,504,890...161,655,212
G
Ppif
peptidylprolyl isomerase F
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PPIF mRNA
CTD
PMID:31734321
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PPP1CB protein
CTD
PMID:21469165
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PPP1R10 mRNA
CTD
PMID:31734321
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
G
Prdx2
peroxiredoxin 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PRDX2 mRNA
CTD
PMID:31734321
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prmt1
protein arginine methyltransferase 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PRMT1 mRNA
CTD
PMID:31734321
NCBI chr 1:95,458,853...95,468,176
Ensembl chr 1:95,458,850...95,468,345
G
Prps2
phosphoribosyl pyrophosphate synthetase 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PRPS2 protein
CTD
PMID:21469165
NCBI chr X:26,975,915...27,013,184
Ensembl chr X:26,976,061...27,013,181
G
Prr15
proline rich 15
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PRR15 mRNA
CTD
PMID:31734321
NCBI chr 4:83,432,002...83,435,582
Ensembl chr 4:83,431,758...83,437,436
G
Prr9
proline rich 9
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PRR9 mRNA
CTD
PMID:31734321
NCBI chr 2:177,599,483...177,600,849
Ensembl chr 2:177,599,483...177,600,849
G
Prrc2a
proline-rich coiled-coil 2A
affects response to substance
ISO
PRRC2A SNP affects the susceptibility to Sodium Dodecyl Sulfate
CTD
PMID:27258892
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
G
Prrg4
proline rich and Gla domain 4
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PRRG4 mRNA
CTD
PMID:31734321
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Prss3
serine protease 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PRSS3 mRNA
CTD
PMID:31734321
NCBI chr 4:70,203,088...70,206,562
Ensembl chr 4:70,203,088...70,206,562
G
Prss8
serine protease 8
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PRSS8 mRNA
CTD
PMID:31734321
NCBI chr 1:182,536,229...182,540,745
Ensembl chr 1:182,536,229...182,540,815
G
Psma2
proteasome 20S subunit alpha 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PSMA2 protein
CTD
PMID:21469165
NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938
G
Psmb10
proteasome 20S subunit beta 10
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PSMB10 mRNA
CTD
PMID:31734321
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psmb9
proteasome 20S subunit beta 9
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PSMB9 mRNA
CTD
PMID:31734321
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Psme3
proteasome activator subunit 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PSME3 protein
CTD
PMID:20332019
NCBI chr10:86,257,672...86,265,458
Ensembl chr10:86,257,668...86,333,804
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PTGR1 mRNA
CTD
PMID:20566472
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PTGS2 mRNA
CTD
PMID:30806763
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PTPRZ1 mRNA
CTD
PMID:31734321
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
Ptx3
pentraxin 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PTX3 mRNA
CTD
PMID:31734321
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Pxdn
peroxidasin
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of PXDN mRNA
CTD
PMID:31734321
NCBI chr 6:46,580,749...46,658,345
Ensembl chr 6:46,580,761...46,658,345
G
Pycard
PYD and CARD domain containing
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of PYCARD protein
CTD
PMID:21469165
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
G
Rab33a
RAB33A, member RAS oncogene family
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of RAB33A mRNA
CTD
PMID:31734321
NCBI chr X:127,694,219...127,706,378
Ensembl chr X:127,694,964...127,706,378
G
Rab7b
Rab7b, member RAS oncogene family
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RAB7B mRNA
CTD
PMID:31734321
NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581
G
Raet1e
retinoic acid early transcript 1E
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RAET1E mRNA
CTD
PMID:31734321
NCBI chr 1:1,662,665...1,664,609
Ensembl chr 1:1,807,644...1,812,755
G
Rara
retinoic acid receptor, alpha
decreases expression
EXP
Sodium Dodecyl Sulfate results in decreased expression of RARA mRNA
CTD
PMID:12815608
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RB1 mRNA
CTD
PMID:31734321
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rccd1
RCC1 domain containing 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RCCD1 mRNA
CTD
PMID:31734321
NCBI chr 1:134,271,870...134,281,556
Ensembl chr 1:134,271,857...134,280,781
G
Rdh12
retinol dehydrogenase 12
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RDH12 mRNA
CTD
PMID:31734321
NCBI chr 6:98,015,465...98,028,388
Ensembl chr 6:98,015,465...98,028,388
G
Repin1
replication initiator 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of REPIN1 mRNA
CTD
PMID:31734321
NCBI chr 4:77,548,724...77,554,242
Ensembl chr 4:77,548,849...77,554,257
G
Rft1
RFT1 homolog
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RFT1 mRNA
CTD
PMID:31734321
NCBI chr16:5,827,063...5,861,120
Ensembl chr16:5,827,088...5,861,120
G
Rgcc
regulator of cell cycle
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of RGCC mRNA
CTD
PMID:31734321
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
G
Rgs1
regulator of G-protein signaling 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of RGS1 mRNA
CTD
PMID:20713136
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rhbdf1
rhomboid 5 homolog 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RHBDF1 mRNA
CTD
PMID:31734321
NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763
G
Rhbdl2
rhomboid like 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RHBDL2 mRNA
CTD
PMID:31734321
NCBI chr 5:136,037,560...136,081,970
Ensembl chr 5:136,037,305...136,081,969
G
Rhno1
RAD9-HUS1-RAD1 interacting nuclear orphan 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RHNO1 mRNA
CTD
PMID:31734321
NCBI chr 4:161,634,047...161,639,437
Ensembl chr 4:161,634,048...161,639,371
G
Rhou
ras homolog family member U
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RHOU mRNA
CTD
PMID:31734321
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
G
Rnd1
Rho family GTPase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of RND1 mRNA
CTD
PMID:31734321
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnf39
ring finger protein 39
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of RNF39 mRNA
CTD
PMID:31734321
NCBI chr20:1,610,027...1,615,516
Ensembl chr20:1,604,794...1,610,283
G
Rpl22l1
ribosomal protein L22 like 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RPL22L1 mRNA
CTD
PMID:31734321
NCBI chr 2:111,754,687...111,756,623
Ensembl chr 2:111,754,687...111,756,625
G
Rptn
repetin
decreases expression increases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RPTN mRNA Sodium Dodecyl Sulfate results in increased expression of RPTN mRNA
CTD
PMID:25240866 PMID:31734321
NCBI chr 2:179,061,768...179,066,056
Ensembl chr 2:179,060,017...179,065,910
G
Rwdd2b
RWD domain containing 2B
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of RWDD2B mRNA
CTD
PMID:31734321
NCBI chr11:26,665,877...26,677,986
Ensembl chr11:26,665,877...26,674,603
G
S100a1
S100 calcium binding protein A1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of S100A1 mRNA
CTD
PMID:25240866
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
G
S100a5
S100 calcium binding protein A5
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of S100A5 mRNA
CTD
PMID:25240866
NCBI chr 2:176,095,332...176,099,546
Ensembl chr 2:176,097,539...176,099,546
G
S100a7a
S100 calcium binding protein A7A
increases expression decreases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of S100A7A mRNA Sodium Dodecyl Sulfate results in decreased expression of S100A7A mRNA
CTD
PMID:25240866
NCBI chr 2:176,151,405...176,155,846
Ensembl chr 2:176,151,288...176,156,441
G
S100a9
S100 calcium binding protein A9
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of S100A9 mRNA
CTD
PMID:17936526
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
S100b
S100 calcium binding protein B
multiple interactions
ISO
Sodium Dodecyl Sulfate results in increased expression of and results in increased secretion of S100B protein
CTD
PMID:24451020
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Samd4a
sterile alpha motif domain containing 4A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SAMD4A mRNA
CTD
PMID:31734321
NCBI chr15:22,616,200...22,831,872
Ensembl chr15:20,134,377...20,348,380
G
Samd9
sterile alpha motif domain containing 9
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SAMD9 mRNA
CTD
PMID:31734321
NCBI chr 4:31,164,639...31,184,278
Ensembl chr 4:31,164,510...31,184,322
G
Sass6
SAS-6 centriolar assembly protein
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SASS6 mRNA
CTD
PMID:31734321
NCBI chr 2:204,546,660...204,578,930
Ensembl chr 2:204,546,660...204,578,927
G
Satb2
SATB homeobox 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SATB2 mRNA
CTD
PMID:31734321
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
G
Saxo2
stabilizer of axonemal microtubules 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SAXO2 mRNA
CTD
PMID:31734321
NCBI chr 1:136,596,445...136,638,444
Ensembl chr 1:136,623,493...136,638,454
G
Scd
stearoyl-CoA desaturase
decreases expression increases expression
EXP ISO
Sodium Dodecyl Sulfate results in decreased expression of SCD1 mRNA Sodium Dodecyl Sulfate results in increased expression of SCD mRNA
CTD
PMID:12815608 PMID:29155129
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SDF2L1 mRNA
CTD
PMID:31734321
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
G
Sec14l1
SEC14-like lipid binding 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SEC14L1 mRNA
CTD
PMID:31734321
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
G
Sec22c
SEC22 homolog C, vesicle trafficking protein
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SEC22C mRNA
CTD
PMID:31734321
NCBI chr 8:121,345,839...121,371,509
Ensembl chr 8:121,350,107...121,370,925
G
Sema3a
semaphorin 3A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SEMA3A mRNA
CTD
PMID:31734321
NCBI chr 4:21,282,398...21,754,834
Ensembl chr 4:21,287,982...21,494,432
G
Serinc3
serine incorporator 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SERINC3 mRNA
CTD
PMID:21621594
NCBI chr 3:152,301,882...152,321,327
Ensembl chr 3:152,301,772...152,321,808
G
Serpinb3
serpin family B member 3
decreases expression increases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SERPINB3 protein Sodium Dodecyl Sulfate results in increased expression of SERPINB3 mRNA
CTD
PMID:20332019 PMID:30806763
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
G
Serpine1
serpin family E member 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SERPINE1 mRNA
CTD
PMID:31734321
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sertad4
SERTA domain containing 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SERTAD4 mRNA
CTD
PMID:31734321
NCBI chr13:104,360,307...104,371,064
Ensembl chr13:104,360,307...104,370,546
G
Sgms2
sphingomyelin synthase 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SGMS2 mRNA
CTD
PMID:31734321
NCBI chr 2:219,889,809...219,967,704
Ensembl chr 2:219,893,572...219,967,546
G
Sh3bp4
SH3-domain binding protein 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SH3BP4 mRNA
CTD
PMID:31734321
NCBI chr 9:89,660,156...89,739,163
Ensembl chr 9:89,660,156...89,739,163
G
Sh3d21
SH3 domain containing 21
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SH3D21 mRNA
CTD
PMID:31734321
NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:138,429,180...138,444,407
G
Shroom3
shroom family member 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SHROOM3 mRNA
CTD
PMID:31734321
NCBI chr14:15,099,415...15,396,832
Ensembl chr14:15,099,423...15,396,915
G
Slc20a1
solute carrier family 20 member 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SLC20A1 mRNA
CTD
PMID:31734321
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a3
solute carrier family 22 member 3
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SLC22A3 mRNA
CTD
PMID:31734321
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc22a4
solute carrier family 22 member 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SLC22A4 mRNA
CTD
PMID:31734321
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
Slc23a2
solute carrier family 23 member 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SLC23A2 mRNA
CTD
PMID:31734321
NCBI chr 3:119,302,651...119,395,289
Ensembl chr 3:119,302,666...119,460,343
G
Slc25a24
solute carrier family 25 member 24
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SLC25A24 mRNA
CTD
PMID:31734321
NCBI chr 2:196,761,076...196,799,236
Ensembl chr 2:196,761,274...196,799,231
G
Slc25a43
solute carrier family 25, member 43
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SLC25A43 mRNA
CTD
PMID:31734321
NCBI chr X:115,977,437...116,011,789
Ensembl chr X:115,977,510...116,011,205
G
Slc27a1
solute carrier family 27 member 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SLC27A1 mRNA
CTD
PMID:31734321
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SLC7A11 mRNA
CTD
PMID:30806763
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc9a9
solute carrier family 9 member A9
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SLC9A9 mRNA
CTD
PMID:31734321
NCBI chr 8:95,232,889...95,797,262
Ensembl chr 8:95,232,905...95,796,318
G
Smoc1
SPARC related modular calcium binding 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SMOC1 mRNA
CTD
PMID:31734321
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
G
Sod1
superoxide dismutase 1
decreases expression increases expression
EXP ISO
Sodium Dodecyl Sulfate results in decreased expression of SOD1 mRNA Sodium Dodecyl Sulfate results in decreased expression of SOD1 protein Sodium Dodecyl Sulfate results in increased expression of SOD1 mRNA
CTD
PMID:12815608 PMID:21469165
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sox7
SRY-box transcription factor 7
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SOX7 mRNA
CTD
PMID:31734321
NCBI chr15:38,180,503...38,187,264
Ensembl chr15:38,180,503...38,187,264
G
Spink6
serine peptidase inhibitor, Kazal type 6
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SPINK6 mRNA
CTD
PMID:31734321
NCBI chr18:36,397,833...36,410,010
Ensembl chr18:36,397,910...36,409,819
G
Spink7
serine peptidase inhibitor, Kazal type 7
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SPINK7 mRNA
CTD
PMID:31734321
NCBI chr18:56,045,996...56,049,761
Ensembl chr18:56,045,930...56,049,744
G
Sprr3
small proline-rich protein 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SPRR3 mRNA
CTD
PMID:25240866
NCBI chr 2:178,027,743...178,028,501
Ensembl chr 2:178,027,425...178,029,891
G
Sprr4
small proline-rich protein 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SPRR4 mRNA
CTD
PMID:25240866
NCBI chr 2:178,082,466...178,083,125
Ensembl chr 2:178,082,871...178,083,104
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SRXN1 mRNA
CTD
PMID:20566472
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
St6galnac2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ST6GALNAC2 mRNA
CTD
PMID:31734321
NCBI chr10:101,910,220...101,928,412
Ensembl chr10:101,909,971...101,915,008 Ensembl chr10:101,909,971...101,915,008
G
Stat6
signal transducer and activator of transcription 6
increases phosphorylation multiple interactions
ISO
Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein WHI P131 inhibits the reaction [Sodium Dodecyl Sulfate results in increased phosphorylation of STAT6 protein]
CTD
PMID:31734321
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stk10
serine/threonine kinase 10
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of STK10 mRNA
CTD
PMID:31734321
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
G
Sult1e1
sulfotransferase family 1E member 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SULT1E1 mRNA
CTD
PMID:31734321
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sult2b1
sulfotransferase family 2B member 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of SULT2B1 mRNA
CTD
PMID:31734321
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Susd1
sushi domain containing 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SUSD1 mRNA
CTD
PMID:31734321
NCBI chr 5:74,157,653...74,281,171
Ensembl chr 5:74,157,773...74,276,291
G
Syngr3
synaptogyrin 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of SYNGR3 mRNA
CTD
PMID:31734321
NCBI chr10:13,710,553...13,715,309
Ensembl chr10:13,704,998...13,715,669
G
Tac1
tachykinin, precursor 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TAC1 mRNA
CTD
PMID:31734321
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Taldo1
transaldolase 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TALDO1 protein
CTD
PMID:21469165
NCBI chr 1:196,493,634...196,503,965
Ensembl chr 1:196,493,589...196,503,974
G
Tcf7l2
transcription factor 7 like 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TCF7L2 mRNA
CTD
PMID:31734321
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
G
Tert
telomerase reverse transcriptase
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TERT mRNA
CTD
PMID:17936526
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tex14
testis expressed 14, intercellular bridge forming factor
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TEX14 mRNA
CTD
PMID:31734321
NCBI chr10:72,231,766...72,356,938
Ensembl chr10:72,231,801...72,355,805
G
Tex261
testis expressed 261
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TEX261 mRNA
CTD
PMID:21621594
NCBI chr 4:116,253,547...116,260,730
Ensembl chr 4:116,244,600...116,260,253
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TFPI2 mRNA
CTD
PMID:31734321
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Thnsl1
threonine synthase-like 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of THNSL1 mRNA
CTD
PMID:31734321
NCBI chr17:83,714,794...83,722,190
Ensembl chr17:83,714,738...83,723,805
G
Tlr2
toll-like receptor 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TLR2 mRNA
CTD
PMID:17936526
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tm4sf1
transmembrane 4 L six family member 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TM4SF1 mRNA
CTD
PMID:31734321
NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146
G
Tmem125
transmembrane protein 125
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TMEM125 mRNA
CTD
PMID:31734321
NCBI chr 5:132,063,162...132,064,566
Ensembl chr 5:132,059,554...132,079,297 Ensembl chr 5:132,059,554...132,079,297
G
Tmem177
transmembrane protein 177
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TMEM177 mRNA
CTD
PMID:31734321
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem45b
transmembrane protein 45b
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TMEM45B mRNA
CTD
PMID:31734321
NCBI chr 8:29,865,276...29,910,453
Ensembl chr 8:29,865,278...29,910,453
G
Tnc
tenascin C
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TNC mRNA
CTD
PMID:31734321
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
increases expression affects expression multiple interactions increases secretion
ISO
Sodium Dodecyl Sulfate results in increased expression of TNF mRNA Sodium Dodecyl Sulfate affects the expression of TNF mRNA Sodium Dodecyl Sulfate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CCL20 protein]; TNF protein affects the reaction [Sodium Dodecyl Sulfate results in increased secretion of CXCL8 protein] Sodium Dodecyl Sulfate results in increased secretion of TNF protein
CTD
PMID:9856837 PMID:15679580 PMID:20385217 PMID:31734321 PMID:36416909
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TNFAIP3 mRNA
CTD
PMID:20146380 PMID:31734321
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip6
TNF alpha induced protein 6
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TNFAIP6 mRNA
CTD
PMID:20713136
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfsf10
TNF superfamily member 10
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TNFSF10 mRNA
CTD
PMID:31734321
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Traf4
Tnf receptor associated factor 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TRAF4 mRNA
CTD
PMID:31734321
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
G
Trim6
tripartite motif containing 6
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TRIM6 mRNA
CTD
PMID:31734321
NCBI chr 1:168,095,619...168,108,809
Ensembl chr 1:158,683,746...158,696,914
G
Trmt12
tRNA methyltransferase 12
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TRMT12 mRNA
CTD
PMID:31734321
NCBI chr 7:90,417,846...90,419,472
Ensembl chr 7:90,417,862...90,419,867
G
Tsen54
tRNA splicing endonuclease subunit 54
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TSEN54 mRNA
CTD
PMID:31734321
NCBI chr10:101,041,607...101,050,088
Ensembl chr10:101,042,503...101,050,087
G
Ttc32
tetratricopeptide repeat domain 32
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TTC32 mRNA
CTD
PMID:31734321
NCBI chr 6:31,834,428...31,841,027
Ensembl chr 6:31,834,428...31,842,621
G
Txn1
thioredoxin 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TXN mRNA
CTD
PMID:20491607
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of TXNRD1 mRNA
CTD
PMID:20566472
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Tymp
thymidine phosphorylase
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of TYMP mRNA
CTD
PMID:31734321
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Ube2e2
ubiquitin-conjugating enzyme E2E 2
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of UBE2E2 mRNA
CTD
PMID:31734321
NCBI chr15:9,411,067...9,688,731
Ensembl chr15:6,980,474...7,257,532
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of UHRF1 mRNA
CTD
PMID:31734321
NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,134,909...1,154,631
G
Ulk4
unc-51 like kinase 4
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ULK4 mRNA
CTD
PMID:31734321
NCBI chr 8:120,670,879...120,966,026
Ensembl chr 8:120,670,866...120,966,924
G
Usp43
ubiquitin specific peptidase 43
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of USP43 mRNA
CTD
PMID:31734321
NCBI chr10:52,549,200...52,611,168
Ensembl chr10:52,548,963...52,611,533
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of VEGFA mRNA; Sodium Dodecyl Sulfate results in increased expression of VEGFA protein
CTD
PMID:9390328 PMID:25617811 PMID:31734321
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of VEGFC mRNA
CTD
PMID:25617811
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:37,712,262...37,827,848
G
Vegfd
vascular endothelial growth factor D
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of VEGFD mRNA
CTD
PMID:20146380
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
G
Vmp1
vacuole membrane protein 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of VMP1 mRNA
CTD
PMID:31734321
NCBI chr10:71,405,058...71,505,045
Ensembl chr10:71,405,452...71,505,007
G
Vps29
VPS29 retromer complex component
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of VPS29 protein
CTD
PMID:21469165
NCBI chr12:34,208,911...34,217,977
Ensembl chr12:34,207,263...34,217,964
G
Vta1
vesicle trafficking 1
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of VTA1 protein
CTD
PMID:21469165
NCBI chr 1:9,032,861...9,080,635
Ensembl chr 1:9,032,335...9,080,635
G
Vwce
von Willebrand factor C and EGF domains
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of VWCE mRNA
CTD
PMID:31734321
NCBI chr 1:207,280,714...207,327,215
Ensembl chr 1:207,282,356...207,312,986
G
Wdr5b
WD repeat domain 5B
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of WDR5B mRNA
CTD
PMID:31734321
NCBI chr11:64,710,945...64,712,804
Ensembl chr11:64,710,355...64,712,807
G
Yod1
YOD1 deubiquitinase
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of YOD1 mRNA
CTD
PMID:31734321
NCBI chr13:42,175,047...42,181,661
Ensembl chr13:42,174,820...42,177,205
G
Zbtb26
zinc finger and BTB domain containing 26
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ZBTB26 mRNA
CTD
PMID:31734321
NCBI chr 3:21,195,319...21,207,925
Ensembl chr 3:21,195,319...21,207,942
G
Zc3h13
zinc finger CCCH type containing 13
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ZC3H13 mRNA
CTD
PMID:31734321
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
G
Zc3h8
zinc finger CCCH type containing 8
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ZC3H8 mRNA
CTD
PMID:31734321
NCBI chr 3:116,176,779...116,193,752
Ensembl chr 3:116,176,798...116,193,787
G
Zc3hav1
zinc finger CCCH-type containing, antiviral 1
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ZC3HAV1 mRNA
CTD
PMID:31734321
NCBI chr 4:67,012,129...67,062,428
Ensembl chr 4:67,012,185...67,062,428
G
Zc3hav1l
ZC3HAV1 like
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ZC3HAV1L mRNA
CTD
PMID:31734321
NCBI chr 4:66,994,192...67,003,207
Ensembl chr 4:66,994,199...67,001,620
G
Zdhhc23
zinc finger DHHC-type palmitoyltransferase 23
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ZDHHC23 mRNA
CTD
PMID:31734321
NCBI chr11:70,224,581...70,240,971
Ensembl chr11:56,718,826...56,734,194
G
Zfp12
zinc finger protein 12
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ZNF12 mRNA
CTD
PMID:31734321
NCBI chr12:11,316,971...11,330,498
Ensembl chr12:11,316,872...11,330,558
G
Zfp185
zinc finger protein 185
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ZNF185 mRNA
CTD
PMID:31734321
NCBI chr X:150,831,869...150,877,652
Ensembl chr X:150,831,862...150,874,810
G
Zfp57
zinc finger protein 57
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ZFP57 mRNA
CTD
PMID:31734321
NCBI chr20:1,521,323...1,534,884
Ensembl chr20:1,521,323...1,529,846
G
Zmiz2
zinc finger, MIZ-type containing 2
increases expression
ISO
Sodium Dodecyl Sulfate results in increased expression of ZMIZ2 mRNA
CTD
PMID:31734321
NCBI chr14:85,465,323...85,481,860
Ensembl chr14:81,251,417...81,267,936
G
Zwilch
zwilch kinetochore protein
decreases expression
ISO
Sodium Dodecyl Sulfate results in decreased expression of ZWILCH mRNA
CTD
PMID:31734321
NCBI chr 8:64,638,401...64,670,911
Ensembl chr 8:64,637,672...64,675,916
G
Casp3
caspase 3
multiple interactions
EXP
6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; [sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Dizocilpine Maleate inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]
CTD
PMID:21873648
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cox4i1
cytochrome c oxidase subunit 4i1
decreases expression
EXP
sodium bisulfite results in decreased expression of COX4 mRNA
CTD
PMID:26980303
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
G
Mt-atp6
mitochondrially encoded ATP synthase membrane subunit 6
decreases expression
EXP
sodium bisulfite results in decreased expression of ATP6 mRNA
CTD
PMID:26980303
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
multiple interactions decreases expression
EXP
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of ATP8 mRNA]
CTD
PMID:26980303
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
multiple interactions decreases expression
EXP
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of COX1 mRNA]
CTD
PMID:26980303
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
decreases expression
EXP
sodium bisulfite results in decreased expression of COX2 mRNA
CTD
PMID:26980303
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt-co3
mitochondrially encoded cytochrome c oxidase III
multiple interactions decreases expression
EXP
TFAM protein inhibits the reaction [sodium bisulfite results in decreased expression of COX3 mRNA]
CTD
PMID:26980303
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
sodium bisulfite inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]
CTD
PMID:25086357
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nrf1
nuclear respiratory factor 1
multiple interactions decreases expression
EXP
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA] sodium bisulfite results in decreased expression of NRF1 mRNA; sodium bisulfite results in decreased expression of NRF1 protein
CTD
PMID:26980303
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions decreases expression
EXP
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of PPARGC1A mRNA] sodium bisulfite results in decreased expression of PPARGC1A mRNA; sodium bisulfite results in decreased expression of PPARGC1A protein
CTD
PMID:26980303
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ptger2
prostaglandin E receptor 2
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER2 protein
CTD
PMID:21873648
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
G
Ptger4
prostaglandin E receptor 4
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER4 protein
CTD
PMID:21873648
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptges
prostaglandin E synthase
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES mRNA
CTD
PMID:21873648
NCBI chr 3:34,575,643...34,586,987
G
Ptges2
prostaglandin E synthase 2
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES2 mRNA
CTD
PMID:21873648
NCBI chr 3:15,690,501...15,697,688
Ensembl chr 3:15,690,501...15,697,688
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
EXP
[SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]
CTD
PMID:21873648
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP ISO
[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Cyclic AMP]; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]; [SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]; [sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein] sodium bisulfite inhibits the reaction [Rotenone results in increased expression of PTGS2 mRNA]; sodium bisulfite inhibits the reaction [Rotenone results in increased expression of PTGS2 protein]
CTD
PMID:21873648 PMID:25086357
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Tfam
transcription factor A, mitochondrial
multiple interactions decreases expression
EXP
Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of TFAM mRNA]; TFAM protein inhibits the reaction [sodium bisulfite results in decreased expression of COX3 mRNA] sodium bisulfite results in decreased expression of TFAM mRNA; sodium bisulfite results in decreased expression of TFAM protein
CTD
PMID:26980303
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Tnf
tumor necrosis factor
multiple interactions
ISO
sodium bisulfite inhibits the reaction [Rotenone results in increased expression of TNF mRNA]
CTD
PMID:25086357
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ahr
aryl hydrocarbon receptor
multiple interactions
EXP
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver
RGD
PMID:23644946
RGD:401794573
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Apoa1
apolipoprotein A1
multiple interactions
EXP
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver
RGD
PMID:23644946
RGD:401794573
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
EXP
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver
RGD
PMID:23644946
RGD:401794573
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Pon1
paraoxonase 1
multiple interactions
EXP
sodium selenate inhibits the reaction [3,3',4,4',5-pentachlorobiphenyl, PCB-126, increases expression of mRNA] in rat liver
RGD
PMID:23644946
RGD:401794573
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Alb
albumin
multiple interactions
ISO
[NOS1 co-treated with sodium sulfite co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased oxidation of ALB protein
CTD
PMID:20348042
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Casp3
caspase 3
multiple interactions
EXP
6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; [sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Dizocilpine Maleate inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; KT 5720 inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]
CTD
PMID:21873648
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Gpt
glutamic--pyruvic transaminase
increases export
ISO
sodium sulfite results in increased export of GPT protein
CTD
PMID:23973939
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Nos1
nitric oxide synthase 1
multiple interactions
ISO
[NOS1 co-treated with sodium sulfite co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased oxidation of ALB protein
CTD
PMID:20348042
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Ptger2
prostaglandin E receptor 2
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER2 protein
CTD
PMID:21873648
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
G
Ptger4
prostaglandin E receptor 4
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGER4 protein
CTD
PMID:21873648
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptges
prostaglandin E synthase
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES mRNA
CTD
PMID:21873648
NCBI chr 3:34,575,643...34,586,987
G
Ptges2
prostaglandin E synthase 2
multiple interactions
EXP
[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGES2 mRNA
CTD
PMID:21873648
NCBI chr 3:15,690,501...15,697,688
Ensembl chr 3:15,690,501...15,697,688
G
Ptgs1
prostaglandin-endoperoxide synthase 1
multiple interactions
EXP
[SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]
CTD
PMID:21873648
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Cyclic AMP]; [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]; [SC 560 results in decreased activity of PTGS1 protein] promotes the reaction [[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Dinoprostone]]; [sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein; Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; PTGS2 protein affects the susceptibility to [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]
CTD
PMID:21873648
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ripk1
receptor interacting serine/threonine kinase 1
increases expression
ISO
sodium sulfite results in increased expression of RIPK1 protein
CTD
PMID:23973939
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
G
Il17a
interleukin 17A
increases expression
EXP
Sodium taurocholate increases expression of Il17a mRNA and protein in the pancreas
RGD
PMID:22990529
RGD:9068935
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Casp3
caspase 3
multiple interactions
EXP
sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]
CTD
PMID:32865837
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
EXP
sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP9 protein]
CTD
PMID:32865837
Ensembl chr 5:154,109,046...154,126,626
G
Mpo
myeloperoxidase
multiple interactions
EXP
sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of MPO protein]
CTD
PMID:32865837
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB1 mRNA
CTD
PMID:33819548
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB4 mRNA
CTD
PMID:33819548
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc1
ATP binding cassette subfamily C member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC1 mRNA
CTD
PMID:33819548
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC2 mRNA
CTD
PMID:33819548
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC3 mRNA
CTD
PMID:33819548
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC4 mRNA
CTD
PMID:33819548
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG2 mRNA
CTD
PMID:33819548
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
G
Abcg5
ATP binding cassette subfamily G member 5
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG5 mRNA
CTD
PMID:33819548
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG8 mRNA
CTD
PMID:33819548
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Adgrg1
adhesion G protein-coupled receptor G1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ADGRG1 mRNA
CTD
PMID:33819548
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH1C mRNA
CTD
PMID:33819548
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH4 mRNA
CTD
PMID:33819548
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
G
Adh6
alcohol dehydrogenase 6 (class V)
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA
CTD
PMID:33819548
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
G
Akr1d1
aldo-keto reductase family 1, member D1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR1D1 mRNA
CTD
PMID:33819548
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Akr7a2
aldo-keto reductase family 7, member A2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA
CTD
PMID:33819548
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Akr7a3
aldo-keto reductase family 7 member A3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A3 mRNA
CTD
PMID:33819548
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Alb
albumin
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ALB mRNA
CTD
PMID:33819548
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ampd3
adenosine monophosphate deaminase 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of AMPD3 mRNA
CTD
PMID:33819548
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Apoa1
apolipoprotein A1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of APOA1 mRNA
CTD
PMID:33819548
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Atp8b1
ATPase phospholipid transporting 8B1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ATP8B1 mRNA
CTD
PMID:33819548
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
G
Baat
bile acid CoA:amino acid N-acyltransferase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of BAAT mRNA
CTD
PMID:33819548
NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:63,850,705...63,860,685
G
Bach1
BTB domain and CNC homolog 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BACH1 mRNA
CTD
PMID:33819548
NCBI chr11:40,425,721...40,461,118
Ensembl chr11:26,939,480...26,972,447
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BCL2L1 mRNA
CTD
PMID:33819548
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Casp9
caspase 9
multiple interactions
EXP
[Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA
CTD
PMID:32981412
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases activity multiple interactions
EXP ISO
Tartrazine results in decreased activity of CAT protein [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CAT mRNA
CTD
PMID:20678534 PMID:33819548
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
multiple interactions
EXP
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of CHRNA4 protein
CTD
PMID:23429044
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
EXP
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of CHRNB2 protein
CTD
PMID:23429044
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
G
Csf1
colony stimulating factor 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of CSF1 mRNA
CTD
PMID:33819548
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2B6 mRNA
CTD
PMID:33819548
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2C18 mRNA
CTD
PMID:33819548
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A4 mRNA
CTD
PMID:33819548
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A5 mRNA
CTD
PMID:33819548
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA
CTD
PMID:33819548
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7B1 mRNA
CTD
PMID:33819548
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP8B1 mRNA
CTD
PMID:33819548
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJB9 mRNA
CTD
PMID:33819548
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:61,269,913...61,275,063
G
Dnajc10
DnaJ heat shock protein family (Hsp40) member C10
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC10 mRNA
CTD
PMID:33819548
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
G
Dnajc18
DnaJ heat shock protein family (Hsp40) member C18
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC18 mRNA
CTD
PMID:33819548
NCBI chr18:27,269,350...27,303,453
Ensembl chr18:27,269,355...27,298,344
G
Dnajc9
DnaJ heat shock protein family (Hsp40) member C9
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA
CTD
PMID:33819548
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of EIF2AK3 mRNA
CTD
PMID:33819548
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Esr1
estrogen receptor 1
increases activity multiple interactions
ISO
Tartrazine results in increased activity of ESR1 protein fulvestrant inhibits the reaction [Tartrazine results in increased activity of ESR1 protein]
CTD
PMID:22562034
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of FMO1 mRNA
CTD
PMID:33819548
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fth1
ferritin heavy chain 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of FTH1 mRNA
CTD
PMID:33819548
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GCLM mRNA
CTD
PMID:33819548
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gjb2
gap junction protein, beta 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GJB2 mRNA
CTD
PMID:33819548
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gprc5b
G protein-coupled receptor, class C, group 5, member B
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GPRC5B mRNA
CTD
PMID:33819548
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
multiple interactions
EXP
[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein
CTD
PMID:23429044
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Gsta1
glutathione S-transferase alpha 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA1 mRNA
CTD
PMID:33819548
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta4
glutathione S-transferase alpha 4
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA4 mRNA
CTD
PMID:33819548
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gstt1
glutathione S-transferase theta 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTT1 mRNA
CTD
PMID:33819548
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
[Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA
CTD
PMID:32981412
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hpx
hemopexin
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of HPX mRNA
CTD
PMID:33819548
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
G
Ifi27
interferon, alpha-inducible protein 27
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IFI27 mRNA
CTD
PMID:33819548
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Il1r1
interleukin 1 receptor type 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IL1R1 mRNA
CTD
PMID:33819548
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of JUN mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of JUN mRNA
CTD
PMID:33819548
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Lipc
lipase C, hepatic type
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of LIPC mRNA
CTD
PMID:33819548
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
G
Ly96
lymphocyte antigen 96
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA
CTD
PMID:33819548
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Maf
MAF bZIP transcription factor
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAF mRNA
CTD
PMID:33819548
NCBI chr19:60,259,200...60,622,145
Ensembl chr19:43,360,342...43,712,365
G
Maff
MAF bZIP transcription factor F
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAFF mRNA
CTD
PMID:33819548
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Map2k2
mitogen activated protein kinase kinase 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP2K2 mRNA
CTD
PMID:33819548
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Map2k6
mitogen-activated protein kinase kinase 6
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAP2K6 mRNA
CTD
PMID:33819548
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA
CTD
PMID:33819548
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mapkapk3
MAPK activated protein kinase 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA
CTD
PMID:33819548
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
G
Mgst1
microsomal glutathione S-transferase 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MGST1 mRNA
CTD
PMID:33819548
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mlkl
mixed lineage kinase domain like pseudokinase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MLKL mRNA
CTD
PMID:33819548
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
G
Mmut
methylmalonyl-CoA mutase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MMUT mRNA
CTD
PMID:33819548
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
G
Mttp
microsomal triglyceride transfer protein
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MTTP mRNA
CTD
PMID:33819548
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR0B2 mRNA
CTD
PMID:33819548
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1H4 mRNA
CTD
PMID:33819548
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I2 mRNA
CTD
PMID:33819548
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I3 mRNA
CTD
PMID:33819548
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Pah
phenylalanine hydroxylase
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PAH mRNA
CTD
PMID:33819548
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3C2A mRNA
CTD
PMID:33819548
NCBI chr 1:170,577,942...170,684,353
Ensembl chr 1:170,577,942...170,683,472
G
Pik3c2g
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PIK3C2G mRNA
CTD
PMID:33819548
NCBI chr 4:172,483,752...172,851,623
Ensembl chr 4:172,484,345...172,850,544
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3R3 mRNA
CTD
PMID:33819548
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PPP1R3C mRNA
CTD
PMID:33819548
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Prkd3
protein kinase D3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PRKD3 mRNA
CTD
PMID:33819548
NCBI chr 6:16,032,507...16,108,444
Ensembl chr 6:16,032,585...16,108,443
G
Rara
retinoic acid receptor, alpha
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RARA mRNA
CTD
PMID:33819548
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rasd1
ras related dexamethasone induced 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RASD1 mRNA
CTD
PMID:33819548
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Rdh16
retinol dehydrogenase 16
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of RDH16 mRNA
CTD
PMID:33819548
NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SERPINE1 mRNA
CTD
PMID:33819548
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC10A1 mRNA
CTD
PMID:33819548
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc22a1
solute carrier family 22 member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC22A1 mRNA
CTD
PMID:33819548
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SOD2 mRNA
CTD
PMID:33819548
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sorl1
sortilin related receptor 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SORL1 mRNA
CTD
PMID:33819548
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SREBF1 mRNA
CTD
PMID:33819548
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Sult2a1
sulfotransferase family 2A member 1
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SULT2A1 mRNA
CTD
PMID:33819548
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Tff1
trefoil factor 1
multiple interactions increases expression
ISO
fulvestrant inhibits the reaction [Tartrazine results in increased expression of TFF1 mRNA]
CTD
PMID:22562034
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,235,736...9,239,597
G
Tlr3
toll-like receptor 3
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR3 mRNA
CTD
PMID:33819548
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR4 mRNA
CTD
PMID:33819548
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions
EXP
[Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA
CTD
PMID:32981412
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf9
TNF receptor superfamily member 9
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA
CTD
PMID:33819548
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of TNFSF10 mRNA
CTD
PMID:33819548
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf11
TNF superfamily member 11
multiple interactions
ISO
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFSF11 mRNA
CTD
PMID:33819548
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Alb
albumin
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of ALB protein
CTD
PMID:39361050
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aqp1
aquaporin 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of AQP1 mRNA
CTD
PMID:39361050
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:84,482,512...84,494,690
G
Aqp2
aquaporin 2
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP2 mRNA
CTD
PMID:39361050
NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:130,711,413...130,716,468
G
Aqp3
aquaporin 3 (Gill blood group)
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP3 mRNA
CTD
PMID:39361050
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Aqp6
aquaporin 6
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP6 mRNA
CTD
PMID:39361050
NCBI chr 7:130,732,216...130,735,149
Ensembl chr 7:130,633,579...130,735,194 Ensembl chr 7:130,633,579...130,735,194
G
Aqp7
aquaporin 7
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of AQP7 mRNA
CTD
PMID:39361050
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of ATP1A1 mRNA; [thallium sulfate results in increased abundance of Thallium] which results in increased expression of ATP1A1 mRNA
CTD
PMID:39361050
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp2c2
ATPase secretory pathway Ca2+ transporting 2
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of ATP2C2 mRNA
CTD
PMID:39361050
NCBI chr19:47,754,120...47,811,369
Ensembl chr19:47,754,120...47,811,368
G
Cacng5
calcium voltage-gated channel auxiliary subunit gamma 5
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CACNG5 mRNA
CTD
PMID:39361050
NCBI chr10:92,827,441...92,869,632
Ensembl chr10:92,829,196...92,869,614
G
Calb1
calbindin 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CALB1 mRNA
CTD
PMID:39361050
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Casr
calcium-sensing receptor
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CASR mRNA
CTD
PMID:39361050
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
G
Clu
clusterin
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of CLU mRNA
CTD
PMID:39361050
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of CYP24A1 mRNA
CTD
PMID:39361050
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Gdf15
growth differentiation factor 15
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of GDF15 mRNA
CTD
PMID:39361050
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of HAVCR1 mRNA
CTD
PMID:39361050
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of HMGCS2 mRNA
CTD
PMID:39361050
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
affects expression
EXP
thallium sulfate affects the expression of HMOX1 mRNA
CTD
PMID:22954530
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNJ1 mRNA
CTD
PMID:39361050
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNJ10 mRNA
CTD
PMID:39361050
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNMA1 mRNA
CTD
PMID:39361050
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
G
Kcnq1
potassium voltage-gated channel subfamily Q member 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of KCNQ1 mRNA
CTD
PMID:39361050
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
G
Lcn2
lipocalin 2
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of LCN2 mRNA
CTD
PMID:39361050
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Mt1
metallothionein 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of MT1F mRNA
CTD
PMID:39361050
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Rgn
regucalcin
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of RGN mRNA
CTD
PMID:39361050
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Scnn1a
sodium channel epithelial 1 subunit alpha
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SCNN1A mRNA
CTD
PMID:39361050
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
G
Slc12a1
solute carrier family 12 member 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC12A1 mRNA
CTD
PMID:39361050
NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899
G
Slc12a3
solute carrier family 12 member 3
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC12A3 mRNA
CTD
PMID:39361050
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc16a7
solute carrier family 16 member 7
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC16A7 mRNA
CTD
PMID:39361050
NCBI chr 7:62,929,067...63,096,995
Ensembl chr 7:61,051,167...61,154,994
G
Slc20a2
solute carrier family 20 member 2
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC20A2 mRNA
CTD
PMID:39361050
NCBI chr16:69,460,850...69,551,418
Ensembl chr16:69,460,462...69,521,711
G
Slc22a12
solute carrier family 22 member 12
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of SLC22A12 mRNA
CTD
PMID:39361050
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
G
Slc26a7
solute carrier family 26 member 7
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC26A7 mRNA
CTD
PMID:39361050
NCBI chr 5:27,884,400...28,021,865
Ensembl chr 5:27,887,042...28,021,658
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC4A1 mRNA
CTD
PMID:39361050
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
G
Slc5a1
solute carrier family 5 member 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC5A1 mRNA
CTD
PMID:39361050
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
G
Slc5a2
solute carrier family 5 member 2
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of SLC5A2 mRNA
CTD
PMID:39361050
NCBI chr 1:182,847,185...182,853,309
Ensembl chr 1:182,847,106...182,853,306
G
Slc7a12
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC7A12 mRNA
CTD
PMID:39361050
NCBI chr 2:87,079,724...87,146,875
Ensembl chr 2:87,079,749...87,146,875
G
Slc7a13
solute carrier family 7 member 13
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC7A13 mRNA
CTD
PMID:39361050
NCBI chr 5:33,277,400...33,298,186
Ensembl chr 5:33,277,416...33,298,092
G
Slc8a1
solute carrier family 8 member A1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC8A1 mRNA
CTD
PMID:39361050
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc9a3
solute carrier family 9 member A3
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLC9A3 mRNA
CTD
PMID:39361050
NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417
G
Slco1a1
solute carrier organic anion transporter family, member 1a1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLCO1A1 mRNA
CTD
PMID:39361050
NCBI chr 4:174,877,045...174,950,900
Ensembl chr 4:174,876,593...174,950,873
G
Slco1a6
solute carrier organic anion transporter family, member 1a6
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of SLCO1A6 mRNA
CTD
PMID:39361050
NCBI chr 4:175,072,143...175,107,950
Ensembl chr 4:175,072,143...175,117,263
G
Spp1
secreted phosphoprotein 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of SPP1 mRNA
CTD
PMID:39361050
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tmem252
transmembrane protein 252
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of TMEM252 mRNA
CTD
PMID:39361050
NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943
G
Trpv5
transient receptor potential cation channel, subfamily V, member 5
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of TRPV5 mRNA
CTD
PMID:39361050
NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:70,536,440...70,562,745
G
Umod
uromodulin
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of UMOD mRNA
CTD
PMID:39361050
NCBI chr 1:173,816,341...173,829,681
Ensembl chr 1:173,816,339...173,830,302
G
Vnn1
vanin 1
multiple interactions
EXP
[thallium sulfate results in increased abundance of Thallium] which results in increased expression of VNN1 mRNA
CTD
PMID:39361050
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]
CTD
PMID:30048646
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Ahr
aryl hydrocarbon receptor
multiple interactions increases activity
ISO
[4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] results in increased activity of AHR protein; Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] Thymol results in increased activity of AHR protein
CTD
PMID:29191726
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
affects localization
ISO
Thymol affects the localization of AIFM1 protein
CTD
PMID:21640085
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Bax
BCL2 associated X, apoptosis regulator
increases expression multiple interactions
ISO EXP
Thymol results in increased expression of BAX protein Thymol inhibits the reaction [imidacloprid results in increased expression of BAX mRNA] Thymol results in increased expression of BAX mRNA
CTD
PMID:21640085 PMID:34171690
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO EXP
Thymol results in decreased expression of BCL2 protein Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA]
CTD
PMID:21640085 PMID:34171690
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions
EXP
Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA]
CTD
PMID:26996544
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Car2
carbonic anhydrase 2
multiple interactions
ISO
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]
CTD
PMID:30048646
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Casp3
caspase 3
increases activity multiple interactions
ISO EXP
Thymol results in increased activity of CASP3 protein Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 mRNA]; Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 protein]
CTD
PMID:21640085 PMID:34171690
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity multiple interactions
ISO EXP
Thymol results in increased activity of CASP8 protein Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA]
CTD
PMID:21640085 PMID:26996544
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases activity
EXP ISO
Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] Thymol results in increased activity of CASP9 protein
CTD
PMID:21640085 PMID:26996544
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO EXP
Thymol inhibits the reaction [Dietary Fats results in decreased activity of CAT protein] Thymol inhibits the reaction [Diethylhexyl Phthalate results in increased activity of CAT protein] Thymol inhibits the reaction [imidacloprid results in decreased activity of CAT protein]; Thymol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]
CTD
PMID:26680107 PMID:26721194 PMID:34171690 PMID:35521929
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ctsk
cathepsin K
multiple interactions
ISO
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]
CTD
PMID:30048646
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:183,058,569...183,069,550
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP11A1 mRNA]
CTD
PMID:34171690
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA]
CTD
PMID:34171690
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP19A1 mRNA]
CTD
PMID:34171690
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Thymol results in increased expression of CYP1A1 mRNA
CTD
PMID:29191726
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dcstamp
dendrocyte expressed seven transmembrane protein
multiple interactions
ISO
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]
CTD
PMID:30048646
NCBI chr 7:70,807,455...70,822,067
Ensembl chr 7:70,807,581...70,822,078
G
Dgat2
diacylglycerol O-acyltransferase 2
multiple interactions
ISO
Thymol inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA]
CTD
PMID:36535314
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428
G
Fas
Fas cell surface death receptor
multiple interactions
EXP
Thymol inhibits the reaction [Isoproterenol results in increased expression of FAS mRNA]
CTD
PMID:26996544
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol promotes the reaction [Lipopolysaccharides results in decreased expression of FOS protein]
CTD
PMID:30048646
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in increased expression of FSHB protein]
CTD
PMID:34171690
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Gab2
GRB2-associated binding protein 2
multiple interactions
ISO
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]
CTD
PMID:30048646
NCBI chr 1:151,429,844...151,625,708
Ensembl chr 1:151,429,695...151,625,031
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
multiple interactions
EXP
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]
CTD
PMID:11399263
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gabrb2
gamma-aminobutyric acid type A receptor subunit beta 2
multiple interactions
EXP
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]
CTD
PMID:11399263
NCBI chr10:26,936,592...27,156,141
Ensembl chr10:26,936,551...27,151,251
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
multiple interactions
EXP
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2]
CTD
PMID:11399263
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
Thymol inhibits the reaction [Dietary Fats results in decreased activity of GSR protein]
CTD
PMID:26680107
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in decreased expression of HSD17B3 mRNA]
CTD
PMID:34171690
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
G
Hspa8
heat shock protein family A (Hsp70) member 8
multiple interactions
ISO
Chloroquine inhibits the reaction [Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein]]; Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein]
CTD
PMID:36535314
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Htr3a
5-hydroxytryptamine receptor 3A
increases activity
ISO
Thymol results in increased activity of HTR3A protein
CTD
PMID:26456648
NCBI chr 8:49,242,018...49,254,475
Ensembl chr 8:49,242,020...49,254,389
G
Il10
interleukin 10
multiple interactions
EXP
[Thymol co-treated with Fluorouracil] results in increased expression of IL10 protein
CTD
PMID:34665902
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Thymol inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA]
CTD
PMID:26801986 PMID:30048646
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
EXP
Thymol inhibits the reaction [Fluorouracil results in increased expression of IL6 protein]
CTD
PMID:34665902
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in increased expression of LHB protein]
CTD
PMID:34171690
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
increases expression multiple interactions
ISO
Thymol results in increased expression of MAP1LC3A protein Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein]
CTD
PMID:36535314
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Mitf
melanocyte inducing transcription factor
multiple interactions
ISO
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA]
CTD
PMID:30048646
NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:130,409,217...130,621,145
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein]
CTD
PMID:30048646
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA]
CTD
PMID:30048646
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nfatc1
nuclear factor of activated T-cells 1
multiple interactions
ISO
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]
CTD
PMID:30048646
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Ogdh
oxoglutarate dehydrogenase
multiple interactions
EXP
Thymol inhibits the reaction [Isoproterenol results in decreased activity of OGDH protein]
CTD
PMID:26721194
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in decreased expression of PCNA protein]
CTD
PMID:34171690
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
Thymol inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]
CTD
PMID:34665902
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Thymol inhibits the reaction [Fluorouracil results in increased expression of RELA protein]
CTD
PMID:34665902
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sqstm1
sequestosome 1
multiple interactions
ISO
Thymol inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]
CTD
PMID:36535314
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
ISO
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]
CTD
PMID:30048646
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
Thymol inhibits the reaction [Dietary Fats results in increased expression of SREBF1 protein]
CTD
PMID:26680107
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Star
steroidogenic acute regulatory protein
multiple interactions
EXP
Thymol inhibits the reaction [imidacloprid results in decreased expression of STAR mRNA]
CTD
PMID:34171690
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO EXP
Thymol inhibits the reaction [Dietary Fats results in increased expression of TGFB1 protein] Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 protein]
CTD
PMID:26680107 PMID:34665902
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Thymol inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA] Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF protein]
CTD
PMID:26801986 PMID:30048646 PMID:34665902
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11a
TNF receptor superfamily member 11A
multiple interactions
ISO
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA]
CTD
PMID:30048646
NCBI chr13:21,928,370...21,986,719
Ensembl chr13:21,928,408...21,986,695
G
Tnfsf11
TNF superfamily member 11
multiple interactions
ISO
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA]
CTD
PMID:30048646
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
ISO
Thymol results in increased activity of TRPV3 protein
CTD
PMID:16617338
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of Thymol
CTD
PMID:14557274
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of Thymol
CTD
PMID:14557274
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
Thymol inhibits the reaction [Dietary Fats results in increased expression of VEGFA protein]
CTD
PMID:26680107
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all